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Alergie towarzyszą człowiekowi niemal od zarania dziejów. Już w starożytnym Egipcie, 
Mezopotamii i Grecji znano reakcje alergiczne na pewne substancje. Alergią nazywamy stan, 
w którym organizm reaguje na substancję niegroźną w sposób gwałtowny i nieadekwatny do 
poziomu rzeczywistego zagrożenia. Reakcja alergiczna może występować pod wpływem 
różnych czynników i pod różnymi postaciami. Astma, wysięk z nosa, wysypka, problemy 
pokarmowe to tylko główne schorzenia związane z alergią. Astma jest jedną z najczęstszych 
(Masoli et al., 2004) i jedną z najpoważniejszych chorób dróg oddechowych, która może być 
powodowana przez alergeny wziewne (Busse and Lemanske, 2001). Przebieg astmy może być 
ostry lub chroniczny i ekspozycja na pyłek, ślinę i naskórek zwierzęcy, odchody roztoczy kurzu 
domowego, różne substancje karalusze, a także substancje niebędące alergenami mogą 
spowodować atak astmy. Poznanie struktury pneumoalergenów oraz próba zrozumienia 
molekularnych podstaw oddziaływań pomiędzy badanymi alergenami i przeciwciałami może 
przyczynić się do opracowania w przyszłości odpowiedniej terapii immunologicznej a tym 
samym zmniejszenia objawów astmy u osób nią dotkniętych.  
Głównym elementem tezy doktorskiej było zbadanie molekularnych podstaw 
oddziaływania głównego alergenu Grupy 1 z roztocza kurzu domowego pochodzącymi z 
Europy Der p 1 (skórożarłoczek skryty - Dermatophagoides pteronyssinus) oraz roztoczy kurzu 
domowego pochodzącymi z Ameryki (Dermatophagoides farinae) Der f 1 z przeciwciałami 
monoklonalnymi 4C1, 5H8 oraz 10B9. Została przeprowadzona szczegółowa analiza 
powierzchni oddziaływania epitopu oraz paratopu w otrzymanych kompleksach alergenu z 
przeciwciałami. 
Zbadanie alergenu Bla g 4 pochodzącego z karaczana prusaka (Blatella germanica) było 
kolejną częścią projektu poznania pneumoalergenów. Alergen ten należy do lipokalin – rodziny 
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białek wiążących małe cząsteczki. Lipokaliny charakteryzują się stosunkowo niewielkim 
zachowaniem ewolucyjnym na poziomie sekwencji, ale silnym na poziomie struktury. Funkcja 
Bla g 4 oraz ligand wiązany przez to białko są nieznane. Rozwiązanie struktury Bla g 4 
umożliwiło identyfikację ligandu, a przeprowadzenie analiz strukturalnych, sekwencyjnych 
oraz filogenetycznych najbliższego homologa – Per a 4 oraz innych spokrewnionych alergenów 
umożliwi w nieodległej przyszłości poznanie ich wzajemnych relacji. 
Poznanie struktury oraz zbadanie homologów alergenu Alt a 1 było ostatnią częścią 
projektu. Alergen Alt a 1 pochodzi z pleśni Alternaria alternata występującej powszechnie w 
klimacie umiarkowanym. Alt a 1 jest alergenem o niez anej strukturze i funkcji. Rozwiązanie 
struktury, oraz analizy sekwencyjne i filogenetyczne będą pierwszym krokiem do przyszłych 
badań nad tym alergenem. 
Kompleksy alergenu Der p 1 z przeciwciałami 10B9 oraz 5H8, a także przeciwciała 
10B9 w niezwiązanej formie dostarczyły unikatowej okazji do przeanalizowania sposobu 
wiązania regionów determinujących komplementarność przeciwciał do epitopów. Bardzo 
bliskie pokrewieństwo Der p 1 oraz Der f 1 oraz różnorodność otrzymanych struktur umożliwiła 
porównanie zmian zachodzących podczas wiązania przeciwciał, a także rodzajów 
uwarunkowań molekularnych do ich wystąpienia. Umożliwiło to porównanie zmian 
zachodzących podczas wiązania przeciwciała 10B9 do Der p 1 w kontekście otrzymanej 
uprzednio struktury alergenów Der p 1 i Der f 1 z podwójnie swoistym przeciwciałem 4C1. 
Otrzymane wyniki prowadzą do wniosku, że nawet takie same lub prawie identyczne epitopy  
mogą zachowywać się zgodnie zarówno z modelem „klucza i zamka” jak i modelem 
indukowanego dopasowania Identyfikacja reszt aminokwasowych odgrywających znaczącą 
rolę w oddziaływaniach alergenu z przeciwciałami oraz zrozumienie strukturalnych podstaw 
komplementarności między nimi może zostać wykorzystane w projektowaniu alergenów o 
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epitopach charakteryzujących się obniżoną siłą wiązania przeciwciał do celów immunoterapii 
alergenowej. 
 Dzięki krystalografii rentgenowskiej możliwe było poznanie szczegółów 
oddziaływania alergenu Bla g 4 z tyraminą, a dzięki analizie struktur oraz sekwencji białek 
homologicznych, będących także alergenami, poznanie zachowanego ewolucyjnie miejsca i 
sposobu wiązania tego ligandu wśród pokrewnych alergenów. Okazuje się, że nawet najbliższy 
homolog Bla g 4 - Per a 4 pochodzący z karalucha amerykańskiego (Periplaneta americana) 
nie ma zachowanych kluczowych aminokwasów odpowiedzialnych za wiązanie tyraminy i 
oktopaminy, więc najprawdopodobniej wiąże inne ligandy oraz pełni inną funkcję.  
Poznanie struktury alergenu Alt a 1, jako unikalnej dimerycznej β-baryłki, a także jako 
pierwszej z całej rodziny białek z grzybów o nieznanej funkcji jest pierwszym krokiem w celu 
dalszych badań nad funkcją oraz powiazaniem struktury z funkcja, co może doprowadzić do 
opracowania nowych form immunoterapii dla osób uczulonych na ten alergen. 
Uzyskanie struktur krystalicznych za pomocą rentgenografii krystalograficznej oraz 
analizy molekularnych podstaw oddziaływania alergenów z przeciwciałami; analizy 
strukturalnej wraz z sekwencyjną między homologicznymi alergenami może w przyszłości 
zostać wykorzystana do celów farmaceutycznych. Wyniki tych badań pokazują, że 





Human kind has been troubled by allergies since the beginning of written history. 
Allergic reactions to certain substances have been known even in the ancient Egypt, 
Mesopotamia or Greece. What we call an allergy is a state when organism reacts to otherwise 
unharmful substance in the violent and inappropriate manner to real danger posed by the given 
substance. An allergic reaction can occur under the influence of different factors and different 
forms. Asthma, rhinitis, rash, digestive problems are the main ailments related to allergies. 
Asthma is one of the most common (Masoli et al., 2004) and one of the most serious diseases 
of the airways caused by inhaled allergens (Busse and Lemanske, 2001). The course of asthma 
may be acute or chronic, and asthma attacks may be caused by exposure to pollen, animal saliva, 
animal dander, feces of the house dust mites, cockroa h particles, as well as certain non-
allergenic. The elucidation of pneumoallergen structures and an attempt to understand the 
molecular basis of the interactions between analyzed all rgens and antibodies may contribute 
to the development of the proper immunotherapy and thus reduce asthma symptoms in people 
affected by it.  
The main part of this project was to analyze the molecular basis of the interaction 
between Group 1 major allergens from house dust mites – Der p 1 coming from European house 
dust mite (Dermatophagoides pteronyssinus) and Der f 1 coming from American house dust 
mite (Dermatophagoides farinae) with 4C1, 5H8 and 10B9 monoclonal antibodies. A detailed 
analysis of the interaction surface between the epitopes and the paratopes of the obtained 
complexes has been conducted. 
The analysis of the Bla g 4 allergen coming from German cockroach (Blatella 
germanica) was another part of the project concerning pneumoallergens. This allergen belongs 
to lipocalin protein family, which usually bind small ligands. The lipocalins are characterized 
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by their relatively low sequence conservation, but strong structural similarity. The function of 
Bla g 4 as well as the ligand it binds were previously nknown, but the structure determination 
of Bla g 4 presented herein allowed for the identification of the ligand. The analysis of the 
structure and sequence of the closest homolog – Pera 4 as well as other homologous allergens 
allow recognition of interrelationships. 
The elucidation of the structure of Alt a 1 was thelast part of the project. The Alt a 1 
allergen comes from black mold (Alternaria alternata), which is common in the outdoor 
environment in the mild climate zones and is a major health hazard for humans when . Both the 
structure and the function of the Alt a 1 allergen are unknown. The structure solution together 
with the analysis of its sequence is the first step for the future research. 
The Der p 1 allergen complexed with monoclonal antibod es 10B9 and 5H8, as well as 
10B9 antibody in its uncomplexed form provided a uniq e opportunity to study the mechanics 
of the binding of the complementarity determining regions to the epitopes. A very close 
homology between the Der p 1 and Der f 1 allergens together with the variety of the obtained 
structures allowed for the comparison of the changes undergoing upon the binding of the 
antibodies, as well as the molecular determinants involved in this process. This includes the 
changes in the conformation of the 10B9 antibody and the comparison with the results of 
previous study on the binding of the cross-reactive antibody 4C1 by Der p 1 and Der f 1. The 
obtained results show that both “lock and key” and “i uced fit” binding models can coexist 
even in the same area of the epitopes. The identification of the amino acid residues having 
important role in the allergen-antibody interactions a d the understanding of the molecular basis 
of the complementarity between them can be used in the design of allergens with the epitopes 
of lesser affinity to the given antibodies that may be beneficial in immunotherapy. 
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 Thanks to x-ray crystallography, it was possible to s udy the details of the Bla g 4 
allergen with tyramine, and as a result of the analysis of the structures together with the 
sequences of its homologs, it was possible to determin  the conservation level of the binding 
site. This, in turn, provided clues to the ligand binding among homologs related to Bla g 4. It 
turned out that even the closest homolog to Bla g 4 – the Per a 4 allergen from the American 
cockroach (Periplaneta americana) does not have conserved key amino acids responsible for 
the binding of tyramine or octopamine, thus most likely it binds to other ligands and serves a 
different purpose.  
Revealing the Alt a 1 allergen structure as a unique dimeric β-barrel protein, as well as 
solving it as a first structure of the whole protein family of unknown function and exclusive to 
fungi, is the first step for further research and identifying structure-function relationship, which 
can lead to the development of the new forms of immunotherapy for Alt a 1 sensitive patients. 
The knowledge gained by the elucidation of the crystal structures with x-ray 
crystallography methods, together with the result of he analysis of the molecular basis of 
allergen-antibody interactions as well as the structure and sequence analysis between the 
homologous allergens, may be used in the future for the pharmaceutical purposes. The outcome 
of the experimental and theoretical approach present d herein shows that the combination of 
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An allergy (or allergic hypersensivity) and allergic diseases have been described in 
various sources since ancient Mesopotamia, Egypt, Asia or America (Bergmann and Ring, 
2014). In short, an allergy is a destructive, hypersensitive inflammatory response of immune 
system to normally harmless substances known as allergens. An allergic response of an 
organism may cause multiple diseases or maladies associ ted with allergies such as asthma, 
allergic rhinitis (hay fever), atopic dermatitis, and food allergy. An atopy can defined as the 
genetic tendency to develop an hypersensivity to comm n allergens (Coca and Cooke, 1923). 
However, the immune system does not always mediate a hypersensivity to specific substance, 
but rather other mechanisms are involved (Szczeklik and Stevenson, 2003; Szczeklik, 1997). 
The terms allergy and atopy are often interchanged, but they are different. Atopy is an 
IgE-mediated immune response, but allergy is any exaggerated immune system response 
regardless of mechanism. 
The allergen-specific lymphocytes play a dominant role in IgE-mediated allergic 
inflammation. In the response to allergic inflammation, mucous membranes present an 
increased sensitivity and may provoke or exacerbate other allergic symptoms by 
non-immunological factors like infection (Jackson et al., 2008; Kelly and Busse, 2008; 
Newcomb and Peebles, 2009; Wu et al., 2008), irritants, or physical exertion (Weiler et al., 
2007). Normal antigen exposure causes IgG antibodies to be produced without visible 
symptoms, a process called lymphocyte sensitization (Hart and Mitchell, 1971). High 
concentrations of IgG, as well as IgE, antibodies have been shown to be of importance in 
allergic bronchopulmonary aspergillosis (Patterson et al., 1986); therefore, medium levels of 
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IgG antibodies to an antigen is not necessarily a sign of allergic disease. However, the presence 
of IgE antibodies may be a result of an allergic inflammation. 
Certain allergic diseases are not mediated by IgE antibodies. Serum sickness (Jackson, 
2000) was the disease that made the term allergy popular. Similarly to anaphylaxis, which is 
caused by complement activated by immunocomplexes containing dextran (Hedin et al., 1976), 
serum sickness is caused by the antibodies of the IgG isotype; however, specific lymphocytes 
mediate the disease in allergic contact dermatitis (Kimber et al., 2002).  
4.2. Allergic asthma 
Asthma is one of the most common diseases in the world. It is estimated that around 
300 million people in the world currently have asthma (Masoli et al., 2004). Asthma is 
becoming more common in the United States and the number of people with asthma increased 
by 2.9% every year from 20.3 million in 2001 to 25.7 million in 2010 (Moorman et al., 2012) 
and accounts for ~1.6 million visits to emergency departments each year (Schappert and 
Rechtsteiner, 2008). In most cases asthma is initiated by IgE antibodies and the full name of 
this malady is IgE-mediated allergic asthma. Asthma can be described as a common, life-long, 
and the most serious, allergic disease that affects today’s society. Asthma is a multiple form 
disorder that affects the freedom of airflow to thelungs by contraction of the bronchial tubes 
caused by hyper responsiveness to inflammation or as a response to the environment, a pathogen 
or drug treatment (Lodge et al., 2011).  
The beginning of this disease can be traced to the infancy or early childhood (Jackson 
et al., 2008). However, adults were also found to be susceptible (Knutsen et al., 2012). Social 
background, age and ethnicity are among the factors that contribute to the development of 
asthma (Moorman et al., 2012). The stages of asthma may be acute or chronic. The rates of 
asthma related deaths have decreased in developed countries in the last two decades 
(Bartolomei-Díaz et al., 2011; Garne et al., 2014; Goldacre et al., 2012; Hasegawa et al., 2013; 
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Lotufo and Bensenor, 2012; Pesut et al., 2011; Prietsch et al., 2012; Roberts et al., 2013), 
perhaps as the result of asthma education and proper treatment (Chawla et al., 2012); however, 
asthma related deaths increased in Taiwan (Hsiao et l., 2013).  
Inhaled allergens can exacerbate asthma symptoms. Fungal spores, cockroach particles, 
feces of the house dust mites, pollen, animal dander and dust are among the top ten most 
common allergens in the United States (Arbes et al., 2007) and they have been intensively 
studied. However, the amount of information that can be obtained from analysis of allergen 
structures exceeds the limitations of other methods. 
4.3. Exacerbating factors 
There are several factors that exacerbate the course f asthma. Exercise (Weiler et al., 
2007), respiratory tract infections caused by viruses (Jackson et al., 2008; Kelly and Busse, 
2008; Wu et al., 2008), Chlamydia or Mycoplasma species (Newcomb and Peebles, 2009), 
nonsteroidal anti-inflammatory drugs (Szczeklik andStevenson, 2003), gastroesophageal reflux 
disease (Coughlan et al., 2001) or allergens. Persist nt exposure to small amounts of indoor 
allergens, mainly coming from house dust mites and cockroaches, takes part in both early 
asthma stages and subsequent symptom escalation (Platts-Mills, 2008).  
There are multiple sources of the inhaled allergens that can provoke asthma symptoms, 
but sensitization to house dust mites (Celedón et al., 2007), cockroach particles (Gruchalla et 
al., 2005), various species of mold from the Alternaria genus (Bush and Prochnau, 2004), and 
cat (Arbes et al., 2007) is significant in the asthma development. The exposure to a number of 
pets (Ownby et al., 2002) and frequent contact withthem during infancy may reduce subsequent 
risk of the future development of allergic sensitiza ion (Bufford et al., 2008). However, 
ownership of a cat does not seem to have this effect (Popp et al., 1990).  
The level of complexity of interactions found in association with these findings is 
significant and it shows involvement of the genotype-environment interactions (Tabery, 2007). 
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Allergen specific immunotherapy, with the use of grass and birch pollen, can prevent the 
development of asthma and reduce risk hyperresponsive ess and asthma in children with 
seasonal allergic rhinitis (Möller et al., 2002) and it has long-term clinical effect (Niggemann 
et al., 2006). 
4.4. Antibody structure and Fab 
Antibodies comprise two identical heavy chains and two identical light chains and have 
a Y-shaped structure; therefore, the symmetry of the antibody can be described as pseudo-
twofold. The stem contains the constant region, named after the fact, that its structure is strongly 
conserved among antibodies. This region triggers various mechanisms as a response to 
recognized antigens (Edelman, 1973; Porter, 1973). There is a group of antibodies, however, 
that has a quite different overall structure that comprises only single variable part of the heavy 
chain.  
The average antibody (Figure 1) consists of two regions, a fragment crystallizable region 
(Fc region) and fragment antigen binding (Fab fragment). The Fc region interacts with the 
surface receptors and the complement proteins and therefore transmits signals from antibodies. 
The Fc region is usually created by the second and thir  constant domain of two heavy chains. 
The Fab is the part of an antibody responsible for binding of an antibody to antigens. The Fab 
fragment is built by one variable and one constant domain of each of the chain (Al-Lazikani et 
al., 1997). Papain can be used to cleave an antibody nto one Fc fragment and two Fab fragments 





Figure 1 Schematic model of an IgG (a) and structure of an IgG (b).  
Two Fab fragments are colored blue and one green colored Fc fragment. The compatibility determining 
regions (CDRs) are in orange circles. The PDB code of the structure used: 1IGT. 
4.5. Paratopes and CDRs 
Antibodies are produced with variety of specificities toward many antigens, yet the 
number of genes coding antibodies is limited. Genes coding the variable region of antibodies 
are segmented and are joined by recombination (Hozumi and Tonegawa, 1976; Matthyssens et 
al.; Tonegawa, 1976). Successful recombination prevents further somatic gene segments 
rearrangements, essentially locking each cell and its progenitors with one type of receptor 
specificity. The order of gene segments is random; therefore, genes coding variable regions of 
light and heavy chains can be unique and expressed by one type of lymphocytes. Thanks to this 
system, it is possible to create an enormous number of different antibodies from a limited 
number of genes. 
The recognition of an antigen is carried by three loops from the light chain (L1, L2 and 
L3) and three loops from the heavy chain (H1, H2 and H3) forming the paratope (Figure 2). 
These loops are called complementarity determining region (CDR). The overall structure of the 
light chain and the heavy chain variable domains is highly conserved with the exception for 
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CDRs (Wu and Kabat, 1970), thus they were rendered a very interesting target for classification. 
There were numerous attempts to classify CDRs and almost all of them focused on identifying 
a small discrete set of main chain conformations – “canonical structures” – that could be used 
to group conformational classes of CDRs (Al-Lazikan et al., 1997; Chothia and Lesk, 1987; 
Martin and Thornton, 1996; Morea et al., 1998; Shirai et al., 1999).  
The CDR H3 loop was hard to classify due to large conformational variety, but in recent 
studies (Nikoloudis et al., 2014; North et al., 2011) much larger datasets allowed for better 
classification and increased the potential for CDR predictability from sequence.  
 
 
Figure 2 An example of the CDR loops (10B9 antibody).  
The CDR loops from light chain are colored in different shades of blue color, the CDR loops from heavy 
chain are colored in different shades of orange. (PDB code: 4POZ)  
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4.6. House Dust Mites 
House dust mites (HDM) are a common source of indoor allergens in households around 
the world and a major cause of perennial asthma world ide (Platts-Mills et al., 1992; Thomas 
et al., 2010). House dust mites can be found in beds, carpets and soft furniture. The members 
of the Dermatophagoides genus feed on dander and small particles of shed skin, which is 
common in their habitat. The digestive enzymes of the house dust mites are potent proteases 
that are abundant in their feces, and are highly allergenic. Der p 1 is a major allergen and a 
cysteine protease (Chapman and Platts-Mills, 1980), that catalyzes the cleavage of the amide 
linkages in a variety of substrates, including α1-antitrypsin, the CD23 receptor on human B 
cells, the IL-2 receptor (CD25) on human T cells and the Der p 1 pro-polypeptide sequence 
(Shakib et al., 2008). Strong evidence suggests tha the allergenicity of Der p 1 is exacerbated 
by Der p 1-related cleavage of these receptors (Schulz et al., 1998; Shakib et al., 1998). The 
exposure to Der p 1 occurs by inhalation of HDM fecal matter and if it is persistent may cause 
the production of IgE antibodies in susceptible individuals. The WHO/IUIS nomenclature 
(Radauer et al., 2014) contains seventeen registered all rgens originating in European house 
dust mite (Dermatophagoides pteronysinnus) and twenty seven allergens from American house 
dust mite (Dermatophagoides farinae). 
The structures of proenzyme and mature forms of recmbinant Der p 1 were determined 
previously (Chruszcz et al., 2009; De Halleux et al., 2006; Meno et al., 2005). The structure of 
natural Der f 1, which has 81% sequence identity to Der p 1 (Figure 3), was determined as well 
(Chruszcz et al., 2009). In addition, structures of natural Der f 1 and natural Der p 1 in complex 
with the Fab fragment of a cross-reactive monoclonal a tibody (mAb) 4C1 were also elucidated 




Figure 3 Der p 1 (green) and Der f 1 (cyan) superimposition. 
Disulfide bridges are yellow (Der f 1 - light green). Cys34 in the active site is colored red (Cys35 from 
Der f 1 is orange). 
 
Herein, I present the crystal structures of Der p 1, isolated from its natural source, 
complexed with the Fab fragment of 5H8 (Der p 1-5H8), Der p 1 complexed with the Fab 
fragment of 10B9 (Der p 1-10B9), and the Fab fragment of mAb 10B9 alone. Both 10B9 and 
5H8 are species specific, whereas the 4C1 antibody is cross-reactive between Der p 1 from D. 
pteronyssinus and Der f 1 from D. farinae. This enabled the Der p 1 epitopes for mAbs 10B9, 
5H8 and 4C1 to be compared with the corresponding surface on Der f 1 (Chruszcz et al., 2012b, 
2009). It was discovered that the Der p 1 epitopes, which bind 4C1 and 10B9 antibodies, 
partially overlap and these two antibodies compete for the same binding site (Chapman et al., 
1987). The 5H8 antibody, however binds to the epitope l cated on a different side of Der p 1, 
and does not compete with 4C1 or 10B9 for binding (Chapman et al., 1987). The binding 
interfaces of Der p 1 with mAbs 4C1, 5H8 and 10B9 with the binding interfaces of all currently 
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known structures of complexes of proteins or peptides with monoclonal antibodies were also 
compared. 
4.7. German cockroach 
One of the first reports associating cockroaches with allergy comes from 1964 (Bernton 
and Brown, 1964). Since then a variety of cockroach llergens have been reported. Most of 
them come from two cockroach species belonging to tw  cockroach families – Blatella 
germanica (German cockroach; Blatellidae family) and Periplaneta americana (American 
cockroach; Blattidae family)(Arruda et al., 1997; L. K. Arruda et al., 1995; L. Karla Arruda et 
al., 1995; Helm et al., 1996; Santos et al., 1999). The German cockroach is most commonly 
found in Europe and the US, while the American cockr ach is more characteristic to South 
America and some regions in Asia. 
The cockroach particles are among the allergens responsible for vast majority of asthma 
(Call et al., 1992; Cohn et al., 2006; Eggleston et al., 1998; Gelber et al., 1993; Matsui et al., 
2003). The inner city households occupants are the most often subject to exposure and 
sensitization to cockroaches (Call et al., 1992; Cohn et al., 2006; Eggleston et al., 1998), but 
also the inhabitants of suburban areas (Matsui et al., 2003) and even the hospital patients 
(Gelber et al., 1993). 
The allergen nomenclature maintained by WHO/IUIS (Radauer et al., 2014) lists nine 
allergens originating in German cockroach and seven allergens originating in American 
cockroach. Four allergen structures from Blattella germanica - Bla g 1 (Mueller et al., 2015), 
Bla g 2 (Gustchina et al., 2005), Bla g 4 (Yih et al., 2009), Bla g 5 (Mueller et al., 2013) and 
one allergen structure from Periplaneta americana - Per a 4 (Yih et al., 2009) have been 
characterized as of 2015. The Bla g 2 allergen is an aspartic protease (Gustchina et al., 2005; 
Pomés et al., 2002) with an unusual hydrogen bonded etwork. The Bla g 4 allergen belongs to 
the lipocalin protein family (L. Karla Arruda et al., 1995), but the ligand it binds, as well as its 
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function, is unknown. Lipocalins are a family of proteins that bind small extra-cellular ligands 
and the overall structure is usually highly conserved despite low sequence similarity among the 
family (Flower, 1996; Flower et al., 2000). The prevalence of serum IgE antibody to 
recombinant Bla g 4 in 73 cockroach allergic patients with asthma ranged from 40% (antigen 
binding radioimmunoassay) to 60% (plaque immunoassay) (L. K. Arruda et al., 1995). 
Bla g 4 is produced in the male reproductive system by both utricles and the conglobate 
gland and is passed within a spermatophore from the mal  to the female during copulation and 
immediately after mating its level dramatically decreases (Fan et al., 2005; Gore and Schal, 
2007). The fate of Bla g 4 protein inside the female is unknown, but it could serve as a structural 
component of the spermatophore or as part of the seminal fluid for sperm protection, storage 
and activation, sperm competition or as a modulator of female reproductive physiology 
(fecundity, ovulation, oviposition) and behavior or other functions (Gillott, 2003).  
4.8. Mold 
The genus Alternaria contains molds occurring naturally on outdoor vegetation. The 
most studied and representative species of Alternaria is Alternaria alternata, a member of the 
imperfect fungi and one of the most important allergenic fungi (Bush and Portnoy, 2001; 
Durham, 1937). Alternaria alternata is listed by WHO/IUIS (Radauer et al., 2014) 
nomenclature as containing twelve allergens, and Alternaria is one of the best-studied molds. 
Sensitization to Alternaria and its correlation to allergic asthma, rhinitis or airway 
hyperresponsiveness have been described in the Unitd States, Europe, Canada and Australia 
(Chan-Yeung et al., 2010; Downs et al., 2001; Fernández Rodríguez et al., 2011; Marks and 
Bush, 2007; Perzanowski et al., 1998). The effects of Alternaria sensitivity were described 
primarily in reports across the United States – from California, through Arizona to Mid-West 
(Bush and Portnoy, 2001; Delfino et al., 1997; O’Hollaren et al., 1991; Stern et al., 2008) and 
around 12.9% among US citizens have positive skin prick test response to Alternaria species 
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(Arbes et al., 2005a). Sensitization and exposure to Alternaria that has been associated with 
asthma in various studies (Arbes et al., 2005b; O’Hollaren et al., 1991), and in the recent reports 
it has been noted that exposure to outdoor than rather indoor Alternaria spores plays a role in 
the sensitization (Pongracic et al., 2010). The spores of Alternaria may be the cause of 
thunderstorm-related outbreak of asthma, caused by increased exposure to the allergen (Nasser 
and Pulimood, 2009; Pulimood et al., 2007) 
Alt a 1 is a major allergen produced by Alternaria alternata is responsible for IgE 
antibody responses in around 80% of Alternaria-allergic patients (Bush and Portnoy, 2001; 
Lopez and Salvaggio, 1985). The closest homolog of Alt a 1 is an isoallergen of 90% sequence 
identity produced by Alternaria brassicicola, that is responsible for fungal pathogenesis 
(brassica dark leaf spot) in Brassicaceae crops (Cramer and Lawrence, 2003; Hong et al., 2005; 
Nowicki et al., 2012). The small number of known Alt a 1 homologs and little structural data 
does not reflect its importance as an allergen. An immunotherapy with standardized Alternaria 
alternata extract significantly reduced a combined symptom and medication score in trial 
involving children with allergic rhinoconjuctivitis and asthma (Kuna et al., 2011). 
Alt a 1 forms a disulfide bond linked dimer of 30 kDa mass and pI of 4.2 as its natural 
form. Under reducing conditions of SDS-PAGE it migrates as two bands of 16.4 and 15.3 kDa. 
Alt a 1 has been successfully cloned and the expressed recombinant allergen has been used to 
measure IgE and IgG antibody responses in Alternaria-sensitive patients (Achatz et al., 1995; 




5. Aims of the work 
Inhaled allergens are exacerbating factors in asthma. The cooperation between Wladek 
Minor’s Laboratory at the University of Virginia with Indoor Biotechnologies created a unique 
opportunity to thoroughly analyze various interactions of the selected allergens with antibodies, 
ligands and themselves to create the background rende ing some aspects of further research 
possible and providing information to help better understand inhaled allergens. The whole 
project consists of three subprojects focusing on allergens having their origin in house dust 
mites (Der p 1), cockroach (Bla g 4) and fungus (Alt a 1). All of the subprojects involved many 
people; therefore, parts of the subprojects not performed by me will be appropriately marked. 
In the subproject where the Der p 1 allergen was anlyzed, the main goal was to find out 
the molecular mechanisms of specific antibody binding in complexes of Der p 1 with three 
monoclonal antibodies (4C1, 10B9 and 5H8) and compare these complexes with the 
homologous Der f 1 allergen and its complex with the cross-reactive 4C1 monoclonal antibody. 
The properties of the interface between complexes of these allergens with antibodies were 
compared with the interfaces of all available complexes of monoclonal antibodies with proteins 
or peptides found in the Protein Data Bank. The results can be used in the development of 
immunotherapy by design of less potent allergens.  
The project involving the Bla g 4 allergen had the research focused at identification of 
the ligand by solving its structure with a bound ligand. The exploration of structural 
conservancy of homologous allergens and finding its implications on ligands that bind to them 
was second part of this project and greatly increased our understanding about this allergen.  
The goal of project involving Alt a 1 allergen was to obtain a high resolution structure 
and to investigate structural relationships among its homologs.  
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6. Materials and Methods 
6.1. Der p 1 
6.1.1. Der p 1 – Data Collection and Structure Determination 
Der p 1 was purified from D. pteronyssinus mite culture as described previously for Der 
f 1 (Chruszcz et al., 2012b). Data were collected a the Structural Biology Center Collaborative 
Access Team 19-BM and 19-ID beamlines (Rosenbaum et al., 2006), and at the 21-ID-D 
beamline of the Life Sciences Collaborative Access Team respectively at the Advanced Photon 
Source, Argonne National Laboratory. Data reduction and structure determination by molecular 
replacement were performed using HKL-3000 (Minor et al., 2006; Otwinowski and Minor, 
1997) which incorporates MOLREP (Vagin and Teplyakov, 1997) and some of the programs 
included in the CCP4 package (Collaborative Computation l Project, 1994). The structure of 
the Fab fragment of mAb 10B9 was determined using the Fab fragment of mAb 4C1 (PDB 
code: 3RVT) as a starting model. Structures of Der p 1 in complex with the Fab fragments of 
mAb 5H8 and 10B9 were determined utilizing the Der p 1 allergen complexed with the Fab 
fragment of mAb 4C1 (PDB code: 3RVW) (Chruszcz et al., 2012b) as the start model. The 
sequences of the mAbs were obtained by sequencing reverse-transcribed mRNA isolated from 
hybridomas producing the mAb (Chruszcz et al., 2009). The models were refined with COOT 
(Emsley and Cowtan, 2004) and REFMAC5 (Murshudov et al., 2011). TLS groups used in the 
refinement of Der p 1 with the Fab fragment of mAb 10B9 were generated using the TLSMD 
web server (Painter and Merritt, 2006). All three structures were validated with MOLPROBITY 
(Davis et al., 2007) and ADIT (Yang et al., 2004).  
Previous results showed that natural Der p 1 binds a calcium ion (Chruszcz et al., 
2012b); therefore, the metal bound by Der p 1-10B9 and Der p 1-5H8 complexes was 
determined to be calcium. Structures and structure factors were deposited to the PDB (Berman 
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et al., 2000) with accession code 4POZ, 4PP1 and 4PP2 for the Fab fragment of mAb 10B9, the 
Der p 1-5H8 complex and the Der p 1-10B9 complex, rspectively. Data collection and 
refinement statistics can be found in Table I. 
 
 Structure (PDB code) 10B9 (4POZ) Der p 1-10B9 (4PP2) Der p 1-5H8 (4PP1) 
Data collection    
Space group P21212 P21 P21 
Cell dimensions: a,b,c (Å) 67.0, 121.8, 55.0 50.7, 74.9, 184.1 47.7, 73.3, 200.3 
α, β, γ (°) 90.0, 90.0, 90.0 90.0, 97.4, 90.0 90.0, 91.1, 90.0 
Resolution (Å) 1.75 (1.75 - 1.78) 2.74 (2.74 - 2.79) 3.00 (3.00 - 3.05) 
Rsym 0.069 (0.633) 0.139 (0.684) 0.165 (0.653) 
I/σI 27.0 (2.2) 14.5 (2.3) 10.0 (2.3) 
Completeness (%) 99.0 (96.9) 99.2 (97.9) 99.9 (100.0) 
Redundancy 5.4 (4.7) 4.3 (4.2) 4.1 (4.2) 
Refinement    
Resolution (Å) 1.75 2.74 3.00 
No. Reflections 43428 34176 26581 
Rwork/Rfree (%) 17.2 / 20.7 20.0 / 26.1 21.9 / 26.5 
No. Atoms    
    Protein 3364 9866 9748 
    Ligand/ion  30 48 
    Water 449 22 74 
B-factors (Å2)    
    Protein 25 47 50 
    Ligand/ion  30 78 
    Water 32 34 27 
r.m.s. deviations    
    Bond lengths (Å) 0.018 0.007 0.009 
    Bond angles (°) 1.8 1.2 1.2 
Table I Data collection and refinement statistics of 10B9, Der p 1-10B9 and Der p 1-5H8. 
Numbers in parentheses refer to the highest resolution shell. 
6.1.2. Der p 1 – Structure analysis of Der p 1 with 10B9 and Der p 1 with 5H8 
Sequences of proteins whose structures are similar to the heavy and light chains of the 
Fab fragments of mAb 10B9, 5H8 and 4C1, were obtained by a BLAST (Altschul et al., 1997, 
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1990; Camacho et al., 2009) search with an expectation value (e-value) of 1e-10 against the 
pdbaa BLAST sequence database (NCBI Resource Coordinators, 2013). The resulting list of 
the structures of the antibodies were downloaded, an  STRIDE (Frishman and Argos, 1995) 
was used to determine their secondary structure. Th antibodies containing an α-helix in the 
CDR H3 region were used to prepare the dataset for the analysis of the Fab fragment of mAb 
10B9 and superposed in PYMOL (Schrodinger LLC, 2010). The CDR regions of these 
structures were compared and analyzed.  
The list of sequences and structures of Fab fragments of monoclonal antibodies 
complexed with various macromolecules were obtained by running a BLAST (Altschul et al., 
1997, 1990; Camacho et al., 2009) search against the pdbaa database (NCBI Resource 
Coordinators, 2013) using the sequences of the Fab fragments of mAbs 5H8, 10B9 and 4C1 as 
queries. The result of these searches was combined a d redundancy was removed. The list of 
obtained structures was used for the preparation of two datasets – the first one, which contains 
structures solved at a resolution of 3.0Å or better and the second one, which contains structures 
solved at a resolution of 3.5Å or better. Preliminary nalysis of the epitope and paratope content 
and hydrogen bonds between them were virtually ident cal for both datasets. All of the analyses 
were performed simultaneously on both datasets, however, the results from the first dataset, 
which contains 314 structures of Fab fragments in complex with protein or peptides solved at 
3.0Å resolution or better, were chosen for this study and are referred to as the dataset, unless 
otherwise noted. PISA (Krissinel and Henrick, 2007) was used to estimate interfaces and 
hydrogen bonds formed by structures in the dataset. Amino acid residues were considered to be 
part of the interface if the calculated buried surface area for a particular residue was greater than 
10 Å2 or was involved in forming hydrogen bonds. 
The amino acid residues involved in the formation of hydrogen bonds between proteins 
were identified with PISA (Krissinel and Henrick, 2007) and a cutoff distance of 3.3 Å for 
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hydrogen bonds was chosen. The salt bridges between D r p 1 and the Fabs of 10B9 and 5H8 
were identified by PISA (Gibbs free energy based) and VMD (distance based) (Humphrey et 
al., 1996). A salt bridge was considered to be formed if the distance between any of the oxygen 
atoms of acidic residues (carboxylate ions; acceptors) and the nitrogen atoms of basic residues 
(ammonium or guanidinum ions; donors) were within te cut-off distance of 4.0 Å (Barlow and 
Thornton, 1983; Kumar and Nussinov, 2002a, 2002b)  
The VMD (Humphrey et al., 1996) program was used for structural conservation 
analysis between Der p 1 and Der f 1. Der p 1 (3F5V), Der f 1 (3D6S), Der f 1-4C1 (3RVV), 
Der p 1-4C1 (3RVW), Der p 1-10B9 (4PP2), and Der p 1-5H8 (4PP1) were the structures used 
for comparison.  
RING (Martin et al., 2011) was used as a tool for analyzing residue interaction networks 
(RINs) in order to describe the protein three-dimensio al structure and the nature of interactions 
(e.g. hydrogen bonds, van der Waals contacts or π-cation interactions and π-π stacking 
interactions). 
6.1.3. Der p 1 – Other techniques 
Residues on the protein’s surface were identified with PYMOL. The pairwise protein 
sequence identity and similarity was calculated using the EMBOSS (Rice et al., 2000) package. 
The overall frequency of amino acid residues are shown per 100 surface-exposed amino acids 
found in all protein chains of Fab-protein or Fab-peptide complexes reported in the PDB 
database (as of 2013). Amino acid residue frequencies calculated this way were used to estimate 
the expected amino acid content of the epitopes and p ratopes in order to compare it with the 
observed amino acid content of the interfaces. 
A program was written in Python with the use of numpy (Oliphant, 2007), matplotlib 
(Hunter, 2007) and mmlib (Painter and Merritt, 2004) libraries to generate three types of plots: 
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(I) bar plots for comparison between observed and expected distribution of the amount of amino 
acids among epitopes and paratopes, (II) rainbow colored bar plots showing the relative amount 
of surface area contributed to the antigen-antibody interface by each type of the amino acid, and 
(III) array plots for displaying the number of hydrogen bonds between epitopes and paratopes 
as a greyscale. The values of the expected number of amino acid residues in the interfaces for 
the bar plot (I) were derived from the frequencies of amino acid residues occurrences in all 
protein sequences found in BLAST nr database. The dataset obtained in the first step of the 
structural analysis was used for plots (II) and (III). The area contributed by a particular amino 
acid residue to the interface in the rainbow colored plot (II) was calculated with PISA. The 
number of hydrogen bonds in antigen-antibody complexes shown on plot (III) was also 
calculated with PISA. Some of the code was developed and used in a previous work (Chruszcz 
et al., 2012b).  
Molecular Operating Environment (MOE) (Chemical Computing Group Inc., 2013) was 
used to verify the potential hydrogen bonds involved in forming the interfaces between Der p 1 
and both Fab fragments of mAb 5H8 and 10B9. Swiss-Pdb Viewer (Guex and Peitsch, 1997) 
was used to display φ and ψ angles of the CDR H3 loop in the Fab fragment of mAb 10B9. 
6.2. Bla g 4 
6.2.1. Bla g 4 – Structure Determination 
Protein production, crystallization, and data collection have been described previously 
(Yih et al., 2009). The reinterpretation of diffraction data using a new methodology included in 
the HKL-3000 package (Minor et al., 2006) is presented herein. During these studies, data 
obtained from both Se-Met labeled and native Bla g 4 crystals (Yih et al., 2009) were 
reinvestigated . The Se-Met and native structures wre determined using the multi-wavelength 
anomalous diffraction (MAD) technique and Molecular Replacement (MR), respectively, by 
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HKL-3000 coupled with SHELXD/C/E (Sheldrick, 2008), MLPHARE (Otwinowski, 1991), 
DM (Cowtan and Main, 1993), ARP/wARP (Perrakis et al., 1999), MOLREP (Vagin and 
Teplyakov, 1997), SOLVE/RESOLVE (Terwilliger, 2004), and selected programs from the 
CCP4 package (Collaborative Computational Project, 1994). Both the Se-Met derivative and 
the native crystal structures were re-examined in the P41212 space group. The models were later 
refined and validated as described in the section 6.1.1. Structures and structure factors were 
deposited to the PDB (Berman et al., 2000) with accession code 4N7D and 4N7C for Se-Met 




 Structure (PDB code) Se-Met (4N7D) Native (4N7C) 
Data collection   
Space group P41212 P41212 
Cell dimensions: a,b,c (Å) 60.17, 60.17, 124.93 60.35, 60.35, 125.41 
α, β, γ (°) 90.0, 90.0, 90.0 90.0, 90.0, 90.0 
Resolution (Å) 2.1 (2.10 – 2.18) 1.75 (1.75 - 1.81) 
Rsym 0.069 (0.38) 0.064 (0.5) 
I/σI 23.71 (4.0) 43.2 (4.75) 
Completeness (%) 100.0 (100.0) 99.9 (100.0) 
Redundancy 5.1 (4.9) 15.0 (14.9) 
Refinement   
Resolution (Å) 2.1 1.75 
No. Reflections 13356 22948 
Rwork/Rfree (%) 17.6 / 21.7 18.6 / 21.3 
No. Atoms   
    Protein 1361 1370 
    Ligand/ion 25 35 
    Water 117 127 
r.m.s. deviations   
    Bond lengths (Å) 0.018 0.024 
    Bond angles (°) 2.0 2.23 
Table II Data collection and refinement statistics of Bla g 4. 
Numbers in parentheses refer to the highest resolution shell. 
6.2.2. Bla g 4 – Sequence analysis 
The dataset used for analysis was prepared by running PSI-BLAST (Altschul et al., 
1997) against the UniProt database (Uniprot version: 2013_2) (Consortium and The Uniprot 
Consortium, 2012) using the sequences of Bla g 4 and Per a 4 (a close homologous protein to 
Bla g 4 from P. americana) as the queries. The searches were executed in two steps. The first 
step allowed for preparation of position-specific scoring matrix (PSSM) profiles that were used 
as queries in the second step. The PSSM profiles were pr pared by performing two independent 
searches with Bla g 4 and Per a 4 as queries with an expectation value (e-value) of 10−5 for three 
cycles. In the second step, the PSSM profiles prepared in the previous step were used to perform 
searches against the database used in the first seach with an e-value of 10−3 until convergence 
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was achieved. The protein structures, homologous to Bla g 4 and Per a 4 were obtained by 
running PSI-BLAST searches with an expectation value of 10-3 against the pdbaa database 
(NCBI Resource Coordinators, 2013) from NCBI. The obtained sequences of the structures 
were then added to the sequence dataset. Identification of a particular sequence membership in 
specific protein family of PFAM (Punta et al., 2012) database was achieved by preparing a 
BLAST database from the PFAM protein families PF00061 (Lipocalin), PF08212 
(Lipocalin-like), PG03973 (Triabin). PFAM database v rsion 26.0 was used. Two allergen 
families (AF015—Lipocalin, AF119—Triabin family) included in AllFam (Radauer et al., 
2008) allergen families database were also added to the dataset. AllFam database version 2011–
09-12 was used. Sequences obtained from searches again t UniProt were subjected to CD-HIT 
(Fu et al., 2012), where sequences with 80% identity or higher were removed. The prepared 
dataset was merged with results from searches against PFAM and pdbaa (Sayers et al., 2012) 
databases, ultimately returning 1561 non-redundant pro ein sequences listed in Lipocalin, 
Lipocalin-like and Triabin PFAM protein families and sequences obtained from other sources. 
CLANS (Frickey and Lupas, 2004) was used to prepare a 2D visualization of sequences 
pairwise similarity by using the Fruchterman–Reingold graph layout algorithm. Clustering was 
performed with an e-value of 10−6 until convergence was achieved. Allergens found in 
identified clusters were aligned with MAFFT (Katoh and Standley, 2013) with the L-INS-I 
option and later adjusted manually in Jalview (Waterhouse et al., 2009) according to the 2D 
projection of the structural alignment of representative allergens found in the sequence 
dataset—Bla g 4, Per a 4, Can f 2 and Equ c 1 (PDB codes: 3EBK, 3EBW, 3L4R and 1EW3) 
prepared in Swiss-PdbViewer (Guex and Peitsch, 1997). 
6.2.3. Bla g 4 – Evolutionary analysis 
Sequences from AllFam families AF015 and AF119 were mapped on the dataset used 
for clustering, then were aligned by MAFFT (Katoh and Standley, 2013) with the L-INS-I 
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option to increase accuracy. The obtained sequence alignment was subjected to MEGA5 
(Tamura et al., 2011). Phylogeny reconstruction was performed using the Maximum-Likelihood 
method with the WAG (Whelan and Goldman, 2001) amino acid substitution model with 
gamma-distributed rates among patterns. The bootstrap method with 1000 replications was used 
to test branch probabilities. 
6.2.4. Bla g 4 – Structure analysis 
The dataset used for structural conservancy of Bla g 4 was obtained after several steps. 
The first step was performing a PSI-BLAST search against the pdbaa BLAST database (as of 
January 2013). The second step was the manual selection of the “best” structures representing 
given blast database record. The “best” structure was defined as the one with the best 
resolution/R-factors values out of a group representing given blast database record. The dataset 
was formed from 39 structures with the following PDB codes: 1AVG, 1DZK, 1EPA, 1EW3, 
1EXS, 1GKA, 1GM6, 1I06, 1N0S, 1PM1, 1QWD, 1S2P, 1SXX, 1XKI, 1YUP, 1Z24, 2A2U, 
2CZT, 2HLV, 2HYS, 2HZQ, 2L5P, 2L9C, 2RA6, 2RD7, 2WWP, 2XST, 3BX7, 3CQR, 3DSZ, 
3DTQ, 3EBW, 3FMZ, 3L4R, 3QKG, 3S26, 3SAO, 4GE1, and4N7C. The structures were then 
retrieved from the PDB and chains homologous to Bla g 4 were used to prepare a structural 
alignment in the VMD (Humphrey et al., 1996) program. Structural conservancy between 
protein structures was measured by using the QH algorithm (O’Donoghue and Luthey-Schulten, 
2003). Calculated QH values for given residues (QRES) were then applied to the Bla g 4 structure, 
instead of B-factor values, and displayed in Pymol (Schrodinger LLC, 2010).  
6.2.5. Bla g 4 – Other techniques 
Solvent-accessible surface areas were calculated with PDBePISA (Krissinel and 
Henrick, 2007). Figures were prepared with Pymol (Schrodinger LLC, 2010). Modeling of the 
binding of two enantiomers of octopamine was performed in Pymol by superposing them on 
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the tyramine molecule with the use of Least Squares (LSQ) algorithm (Kabsch, 1978, 1976) 
implemented by Jason Vertrees in an extension to Pymol. DALI (Holm and Rosenström, 2010) 
and FATCAT (Ye and Godzik, 2004) were used for search to identify similar proteins. 
6.3. Alt a 1 
6.3.1. Alt a 1 – Data Collection and Structure Determination 
Protein production, crystallization, and data collection have been described previously 
in supplementary materials (Chruszcz et al., 2012a). D ta collection was performed at the 
19-BM Beamline of the Structural Biology Center (Rosenbaum et al., 2006) and the 21-ID-G 
Beamline of the Life Sciences Collaborative Access Team at the Advanced Photon Source 
(Argonne, Il). Data were collected at 100K and processed with HKL-2000 (Otwinowski and 
Minor, 1997). The initial model was obtained from a low-resolution dataset (2.8 Å) collected at 
19-BM from a crystal soaked in a solution containing the Ta6Br122+ cluster. The 
single-wavelength anomalous diffraction technique was used for structure determination. 
Calculations were performed with HKL-3000 (Minor et al., 2006; Otwinowski and Minor, 
1997), which integrates SHELXC/D/E (Sheldrick, 2008), MLPHARE (Otwinowski, 1991), DM 
(Cowtan and Main, 1993), PARROT (Zhang et al., 1997), RESOLVE (Terwilliger, 2004), 
ARP/wARP (Perrakis et al., 1999), and selected programs from the CCP4 package 
(Collaborative Computational Project, 1994). The partial model was obtained by using a 
combination of manual building and building with RESOLVE. This model was used as a 
starting model for building with ARP/wARP. For the ARP/wARP calculation, a 
higher-resolution native dataset (1.9 Å) collected at 21-ID-G was used. The model was later 
updated with COOT (Emsley and Cowtan, 2004) and refined and validated as described in the 
section paragraph 6.1.1. The coordinates and structure factor for Alt a 1 were deposited in the 
PDB (Berman et al., 2000) with accession code 3V0R. Statistics from data processing and 
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structure determination are reported in Table III. 
 Structure (PDB code) 3V0R 
Data collection  
Space group I4122 
Cell dimensions: a,b,c (Å) 70.0, 70.0, 179.3 
α, β, γ (°) 90.0, 90.0, 90.0 
Resolution (Å) 1.90 (1.90 – 1.93) 
Rsym 0.068 (0.777) 
I/σI 59.4 (4.2) 
Completeness (%) 99.9 (100.0) 
Redundancy 13.8 (13.9) 
Refinement  
Resolution (Å) 1.90 
No. Reflections 18063 
Rwork/Rfree (%) 16.7 / 19.0 
No. Atoms  
    Protein 1014 
    Ligand/ion 61 
    Water 161 
B-factors (Å2)  
    Protein 42.7 
    Ligand/ion 57.4 
    Water 54.0 
r.m.s. deviations  
    Bond lengths (Å) 0.020 
    Bond angles (°) 1.9 
Table III Data collection and refinement statistics of Alt a 1.  
Numbers in parentheses refer to the highest resolution shell. 
6.3.2. Alt a 1 – Sequence analysis 
The dataset used in analysis was prepared from the sequences obtained by running 
PSI-BLAST (Altschul et al., 1997) against non-reduna t (nr) BLAST database (Sayers et al., 
2012) with Alt a 1 sequence (gi number: 14423645) as a query. Searches were performed with 
expectation value (e-value) of 0.001 until convergence was achieved. All the sequences 
retrieved in the first step were also used for reciprocal PSI-BLAST searches to identify distant 
homologs. Sequences were retrieved from GenBank. Sequences annotated as incomplete were 
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removed. The final sequence dataset was aligned using MAFFT (Katoh and Standley, 2013) 
with L-INS-I option and further manually refined inJalview (Waterhouse et al., 2009) and 
Bioedit (Hall, 1999) with regard to secondary strucure obtained from STRIDE (Frishman and 
Argos, 1995). CD-HIT (Fu et al., 2012) was used to reduce the size of the dataset by removing 
the sequences of 80 percent of higher pairwise identity.  
6.3.3. Alt a 1 – Evolutionary analysis 
Two datasets have been prepared. The first dataset was prepared from the results of a 
PSI-BLAST (Altschul et al., 1997) search with Alt a 1 llergen sequence (gi number: 14423645) 
against nr BLAST database (NCBI Resource Coordinators, 2013) and then reducing the number 
of sequences with CD-HIT (Fu et al., 2012) by removing the sequences of 80% or higher 
identity. The MEGA package (Tamura et al., 2011) was used for phylogenetic analysis. The 
tree was computed by using the Maximum Likelihood stati tical method with the WAG 
(Whelan and Goldman, 2001) amino acid substitution model. The number of discrete gamma 
categories with Invariant sites (G+I) was set to 5. Gaps and missing data were treated as 
complete deletion. The Nearest-Neighbor-Interchange was used as a maximum likelihood 
heuristic method. The initial tree was prepared automatically. Phylogeny was tested with the 
bootstrap method by using 1000 replications. The multiple sequence alignment programs – 
CLUSTAL W (Thompson et al., 1994) and CLUSTAL X (Larkin et al., 2007) - were used to 
prepare initial version of the alignment that was used to analyze cysteine conservation within 
Alt a 1 homologs. The overall conservancy was mapped on the Alt a 1 structure with Consurf 
(Ashkenazy et al., 2010; Celniker et al., 2013). 
6.3.4. Alt a 1 - Other computational methods 
The STRIDE (Frishman and Argos, 1995) was used to determine the secondary structure 
of Alt a 1. The search for similar structures was performed with DALI (Holm and Rosenström, 
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2010) and FATCAT (Ye and Godzik, 2004) against the structures deposited in PDB (Berman 
et al., 2000). PISA (Krissinel and Henrick, 2007) was used for analysis of the oligomeric 
assembly and calculation of the dimer’s interface area. Figures were prepared with PYMOL 
(Schrodinger LLC, 2010). Electrostatic surface was c lculated in APBS (Baker et al., 2001) 
with model prepared by PDB2PQR (Dolinsky et al., 2007, 2004). The identity and similarity 
values were calculated with lalign program from theFASTA package (Pearson and Lipman, 
1988). 
7. Results 
7.1. Der p 1 
Der p 1 with the Fab fragment of mAb 5H8 and Der p 1 with the Fab fragment of mAb 
10B9 were purified, crystallized, and their structures were determined. Space groups were 
identified as P21212 for the Fab fragment of mAb 10B9 and P21 for the Der p 1-5H8 and 
Der p 1-10B9 complexes. Previously, the crystal structure of Der p 1 complexed with the Fab 
fragment of mAb 4C1 (Chruszcz et al., 2012b) was elucidated. Figure 4 shows the relative 
position of the Fab fragments of 4C1, 10B9 and 5H8 antibodies in complex with Der p 1. More 
than 70% of the 10B9 binding epitope overlaps with the epitope that binds the 4C1 antibody; 
the epitope binding 5H8 antibody is located on a different part of Der p 1. 
The electron density found in close proximity to Asn52 in each of the Der p 1 chains 
was interpreted as N-acetylglucosamine in the structures of both complexes, additionally it was 
discovered that the same, or similar, residue binds N-acetylglucosamine in the structures of 
Group 1 dust mite allergens previously solved, where in case of Der f 1 N-acetylglucosamine 
was bound by Asn53 (Chruszcz et al., 2012b, 2009). An exception was found in a structure 
where Asn52 was replaced by Gln52 (De Halleux et al., 2006). The N-acetylglucosamine 
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binding site is far from the 4C1, 10B9 or 5H8 epitoes and does not interfere with the binding 
of these antibodies. 
 
Figure 4 The relative position of Der p 1, Fab of 5H8, 4C1 and 10B9. 
The Fab fragments of antibodies are colored as follows 4C1 blue, 10B9 red and 5H8 orange. Der p 1 is 
represented as green surface with epitopes binding each antibody colored in similar color to the 
corresponding antibody. Overlapping area of 4C1 and 10B9 binding epitopes is purple.  
Three well-ordered complementarity-determining regions (CDRs) per antibody chain 
are involved in forming the interface areas (Figure 5). The conformations of the CDRs in the 
Fab fragments of mAb 10B9 and 5H8 classified according to the rules described by North et al. 
(North et al., 2011) can be categorized into the same categories as the CDRs of mAb 4C1 
(Chruszcz et al., 2012b); CDR L1 – L1-11-2; CDR L2 – L2-8-1; CDR L3 – L3-9-cis7-1; CDR 






Figure 5 Comparison of CDRs of (a) 4C1, (b) 10B9 and (c) 5H8 antibodies.  
Light chains are marked in the shades of orange, heavy chains are marked in shades of blue. Secondary 






 Der f 1 Der p 1 ASA (Å2) BSA (Å2) 
   Chains A/B with VH of 5H8 
  Tyr48 Tyr47 16.8/15.3 16.8/15.3 
  Arg52 Arg51 142.3/139.5 65.2/66.9 
*   Thr54 Gln53 98.2/97.0 79.7/77.2 
  Ser55 Ser54 86.9/87.0 16.6/15.2 
  Leu56 Leu55 18.2/18.4 13.4/13.5 
  Gln85 Gln84 49.4/50.8 15.5/15.4 
  Asn87 Asn86 79.2/77.7 11.0/11.0 
*   Glu91 Gln90 46.6/47.4 39.5/38.7 
*   Ser94 Tyr93 120.4/119.6 57.1/55.1 
  Asn108 Asn107 152.1/153.2 73.4/75.6 
*   Ser109 Ala108 24.5/24.0 24.4/24.1 
  Gln110 Gln109 133.5/137.0 127.5/130.8 
*   His111 Arg110 95.1/98.8 54.0/53.7 
*   Tyr112 Phe111 37.6/39.4 37.6/39.4 
  Gly113 Gly112 20.4/20.8 18.0/19.0 
  Ser115 Ser114 83.3/78.0 10.4/10.8 
   Chains A/B with VL of 5H8 
  Tyr51 Tyr50 100.9/102.3 13.1/16.1 
  Arg52 Arg51 142.3/139.5 77.1/72.1 
*   Asn53 Gln53 98.2/97.0 10.5/7.3 
  Ser115 Ser114 83.3/78.0 72.1/66.8 
  Ile222 Ile221 77.7/78.8 21.3/21.7 
*   Met223 Leu222 43.7/46.0 40.8/43.7 
Table IV The 5H8-binding epitope on Der p 1 and the corresponding residues of Der f 1.  
Different amino acids between Der p 1 and Der f 1 are indicated with an asterisk. The amino acids with 
buried surface area that were calculated as less than 10 Å2 to the interface were omitted. ASA - 
Accessible Surface Area, BSA - Buried Surface Area. The values of ASA and BSA are presented for 





5H8 ASA (Å2) BSA (Å2) 
VH Chains F/D 
Ser28 64.6/64.0 11.3/11.2 
Thr30 83.3/84.0 25.1/25.0 
Gly31 46.0/46.2 45.9/46.2 
Tyr32 46.0/48.3 13.3/14.9 
Gly33 10.9/10.8 10.0/10.4 
Trp52 60.9/59.6 60.9/59.5 
Gly35 17.3/17.9 11.2/11.2 
Asp54 102.3/101.0 41.3/39.8 
Arg56 135.8/133.9 58.7/58.8 
Asp58 37.0/38.7 16.7/16.6 
Gln100 118.6/115.8 77.8/77.7 
Arg101 131.2/124.6 114.3/108.0 
Tyr102 95.0/98.0 86.2/88.6 
Asp103 93.9/92.7 59.4/59.9 
Tyr105 89.5/90.9 10.2/9.0 
VL Chains E/C 
Thr30 64.0/67.3 40.5/43.0 
Tyr32 94.0/93.8 46.8/48.6 
Tyr50 78.7/78.0 26.5/27.5 
Gly91 35.6/35.3 12.1/11.9 
Lys92 89.5/87.3 60.3/59.0 
Thr93 63.1/70.8 19.3/23.4 
Leu94 141.3/139.5 14.9/7.5 
Table V The Der p 1-binding paratope on the 5H8 antibody.  
The amino acids with buried surface area that were calculated as less than 10 Å2 to the interface were 
omitted. ASA - Accessible Surface Area, BSA - Buried Surface Area. 
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7.1.1. The Der p 1 – 5H8 complex 
Crystals of Fab 5H8 alone were not obtained. In the structure of the Der p 1-5H8 
complex, the epitope binding 5H8 to Der p 1 is located far from the Der p 1’s active site. The 
buried surface area at the interface of Der p 1 and 5H8 is around 910 Å2. The interface areas 
contributed by the heavy and light chains are around 75% and 25%, respectively.  
Der f 1 Der p 1 
5H8 Distance (Å) 
VL VH Chains A/B 
Arg52 Arg51   Asp103 3.0/2.9 
    Gly91   2.7/3.0 
Thr54 Gln53   Asp58 2.5/2.7 
Ser55 Ser54   Arg56 2.9/3.0 
Gln85 Gln84   Arg101 2.6/2.4 
Ser94 Tyr93   Thr30 2.5/2.6 
Ser109 Ala108   Gln100 3.2/3.1 
Gln110 Gln109   Gly53 2.9/3.1 
His111 Arg110   Gln100 2.7/2.7 
      Tyr102 2.6/2.6 
Gly113 Gly112   Asp103 3.2/3.1 
Ile114 Ile113   Arg101 2.5/3.2 
Ser115 Ser114 Tyr32   2.9/3.0 
    Tyr50   3.1/3.0 
Met223 Leu222 Lys92   2.4/2.8 
Table VI The hydrogen bonds formed between Der p 1 and the Fab of mAb 5H8. 
Der f 1 was added to highlight the differences in Der p 1 residues that form the 5H8 binding epitope. 





The Der p 1 epitope binding 5H8 antibody is formed by nineteen amino acids, where 
sixteen residues from Der p 1 interact with fifteen r sidues from the heavy chain and six residues 
from Der p 1 interact with seven residues from the light chain of 5H8 antibody (Table IV and 
Table V).  
 
Figure 6 The surface of Der p 1 with various aspects of structure highlighted.  
The surface of Der p 1 highlighting the epitope for the Fab fragments of mAb 4C1 (figures a and d), 
10B9 (figures b and e), and 5H8 (figures c and f) are shown in surface representation. The colors of the 
epitopes are based on the chains of the antibodies that are being bound. The 4C1-binding epitope is 
colored as follows: pink (VH), dark pink (VH and VL). The 10B9-binding epitope is colored as follows: 
orange (VH), light orange (VH and VL) and yellow (VL only). The 5H8-binding epitope is colored as 
follows: dark cyan (VH), blue (VH and VL) and cyan (VL only). Panels d, e and f represent the structural 
conservation between Der p 1 and Der f 1 calculated with VMD. The color scale starts from dark blue 
(high structural conservation), goes through white and ends in red (no structural conservation) 
The amino acid residue composition of the epitope on the surface of Der p 1 (Figure 6a-
f) where the Fab of mAb 5H8 is bound differs significantly from those epitopes where the Fab 
of mAb 4C1 and 10B9 are bound. Fifteen hydrogen bonds were identified between Der p 1 and 
5H8 antibody. Residue Arg51 of Der p 1 forms hydrogen bonds with both the VL and VH chains 
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of mAb 5H8 (Gly91 and Asp103 respectively). Some of the residues, such as Ser114 with Tyr32 
and Tyr50 and C-terminal Leu222 with Lys92, form hydrogen bonds only with the VL chain, 
while residues Gln53, Ser54, Gln84, Tyr93, Ala108, Gln109, Arg110, Gly112, and Ile113 form 
hydrogen bonds only with the VH chain of 5H8 antibody (Table VI). Figure 11 and Figure 12 
demonstrate that hydrogen bond formation is quite specific, where a tyrosine residue from the 
antibody tends to form hydrogen bonds with an arginine residue from the antigen. This 
occurrence can be observed at the interfaces between D r p 1-4C1 and Der p 1-5H8, but not in 
Der p 1-10B9 complex (Figure 7 and previous work (Chruszcz et al., 2012b)). Arg51 forms 
cation-π interactions with Tyr32 of VL and Tyr102 of VH. The amino acids that make up mAb 
5H8’s paratope of the 5H8-Der p 1 interface are tyrosine, arginine, aspartate, glutamine, lysine 
and a relatively high content of glycine. Phe111 of Der p 1 forms π-π stacking interactions with 
Trp52 (edge-to-face orientation) and Tyr102 (face-to- dge orientation) of VH as well as Tyr47 
of Der p 1. The Fab fragment of mAb 5H8, which is similar to the Fab fragment of mAb 10B9, 
is also a species-specific antibody. It binds to a different fragment of Der p 1 and the epitope 





Figure 7 The hydrogen bonds formed between various complexes. 
The hydrogen bonds formed between (a) Der p 1 and Fb fragment of mAb 10B9 (two copies from 
asymmetric unit), (b) Der p 1 and Fab fragment of mAb 5H8 (two copies from asymmetric unit), (c) all 
non-redundant structures of complexes of proteins wth Fab fragments of monoclonal antibodies and (d) 
all non-redundant peptides with Fab fragments of monoclonal antibodies. The proteins and peptides 
complexes used for analyses were solved at resolution equal or higher than 3.0 Å. Number of hydrogen 
bonds between particular amino acids is shown in greyscale (on right) where the higher number of 
hydrogen bonds, the darker square is marked on figure. Antibodies are on X axis, antigens on Y axis of 
each plot.  
7.1.2. The Der p 1 – 10B9 complex and 10B9 in uncomplexed form 
The epitope for the Fab fragments of mAb 10B9 is also located far from the catalytic 
site of the enzyme (Cys34). The buried surface area t the interface of Der p 1 and 10B9 is 815 
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Å2 and the interface areas contributed by the heavy chain and light chain are around 75% for 
the former and 25% for the latter (Table VII).  
Der f 1 Der p 1 
10B9 Distance (Å) 
VL VH Chains E/F 
Ser13 Ala12   Tyr53 2.7/2.6 
Glu14 Glu13   Arg98 2.9/3.0 
      Arg98 2.8/2.7 
Asp16 Asp15   Tyr107 2.8/2.7 
Ser19 Gln18 Gly91   3.3/3.2 
    Asn92   3.3/3.5 
Arg20 Arg20 Ser30   2.9/NA 
Ser180 Asn179   Ser31 2.6/2.7 
      Gly32 3.0/2.8 
Gln182 Gln181   Ser31 3.6/3.3 
Gly183 Gly182   Ser31 2.8/2.8 
Asp199 Asp198   Tyr106 2.7/2.8 
    Arg53   2.7/3.0 
    Arg53   3.0/3.2 
Ser200 Asn199 Arg53   2.5/2.7 
Table VII The hydrogen bonds formed between Der p 1 and the Fab of mAb 10B9.  
Der f 1 was added to highlight the differences in Der p 1 residues that form the 10B9 binding epitope. 
The hydrogen bonds were estimated by PISA and MOE. The residues forming hydrogen bonds are 
shown in rows. Underlined amino acids also form the salt bridges. 
The Der p 1 epitope that binds 10B9 is formed by seventeen amino acids, where fifteen 
residues from Der p 1 interact with eleven residues from the heavy chain and five residues from 





 Der f 1 Der p 1 ASA (Å2) BSA (Å2) 
   Chains F/E with VH of 10B9 
*   Ser13 Ala12 94.7/90.2 86.2/79.3 
  Glu14 Glu13 111.5/113.9 78.9/83.5 
  Asp16 Asp15 29.5/29.8 24.3/26.1 
  Arg18 Arg17 55.2/62.7 26.9/26.1 
*   Ser19 Gln18 151.7/147.1 46.9/45.7 
  Arg157 Arg156 199.1/197.0 14.9/12.2 
*   Gly179 Ser178 17.1/16.6 13.6/11.8 
*   Ser180 Asn179 82.5/83.3 80.2/79.2 
*   Thr181 Ala180 40.4/45.4 40.4/45.1 
  Gln182 Gln181 145.93/134.8 35.7/30.1 
  Gly183 Gly182 77.5/79.2 18.5/19.9 
  Asp185 Asp184 65.1/61.5 16.0/15.2 
  Tyr186 Tyr185 31.6/34.9 30.7/34.2 
  Asp199 Asp198 56.4/54.1 25.9/25.5 
  Tyr204 Tyr203 30.0/32.5 29.3/30.8 
   Chains F/E with VL of 10B9 
  Arg18 Arg17 55.2/62.7 14.8/16.3 
*   Ser19 Gln18 151.7/147.1 104.4/99.2 
  Arg21 Arg20 153.8/166.1 41.2/43.5 
  Asp199 Asp198 56.4/54.1 26.7/26.0 
*   Ser200 Asn199 103.7/96.5 27.4/23.2 
Table VIII The 10B9-binding epitope on Der p 1 and the corresponding residues of Der f 1. 
The table presents the amino acids that form the 10B9 binding epitope on Der p 1 and the complimentary 
amino acids found on Der f 1. The differences are indicated with an asterisk. The amino acids with 
buried surface area that were calculated as less than 10 Å2 to the interface were omitted. ASA - 







10B9 ASA (Å2) BSA (Å2) 
VH Chains A/C 
Ser31 69.3/65.4 58.1/57.4 
Gly32 12.0/10.6 10.7/9.4 
Phe33 33.8/36.4 33.8/36.1 
Tyr53 115.0/112.1 85.0/81.2 
Thr56 88.7/88.4 15.1/10.8 




Val104 36.3/35.9 36.0/34.9 
Asn105 82.1/80.5 76.7/76.1 
Tyr106 172.8/173.6 50.4/49.7 
Tyr107 164.3/161.9 83.0/82.2 
VL Chains B/D 
Ser30 59.8/57.7 33.8/41.1 
Tyr32 102.7/104.7 61.2/60.1 
Arg53 136.2/134.0 56.5/59.0 
Asn92 55.3/55.8 36.7/38.4 
Tyr96 111.7/114.2 14.4/15.9 
Table IX The Der p 1-binding paratope on the 10B9 antibody. 
The table presents the amino acids that form the Der p 1 binding paratope on the Fab fragment of mAb 
10B9. The amino acids with buried surface area that were calculated as less than 10 Å2 to the interface 
were omitted. ASA - Accessible Surface Area, BSA - Buried Surface Area. 
The uncomplexed Fab fragment of mAb 10B9 crystallized in the orthorhombic space 
group P21212. The overall conformation is almost identical to the Fab fragment of mAb 10B9 
that crystallized in complex with Der p 1, however there are conformational differences between 




Figure 8 The stereogram of the CDR H3 loop of 10B9 (residues 98-110) in two forms. 
The CDR H3 loop on VL 10B9 between residues 98 and 110 in the complexed and uncomplexed form 
is shown in stereo. The uncomplexed form of the Fabfr gment of mAb 10B9 is colored green; the 
complexed form with Der p 1 is colored blue. 
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A superposition of CL, CH, VL, VH from the 10B9 crystal and corresponding chains from 
10B9 from the complex with Der p 1 have a root mean square deviation of 0.8 Å. CDRs L1 
(residues 23 to 34), L2 (residues 49 to 56), L3 (residues 88 to 97), H1 (residues 23 to 36) and 
H2 (residues 50 to 67) have the same side chain conformations and almost identical placement 
of Cα atoms in both the non-bonded and bound antibody structures. However, CDR H3 
(residues 98 to 110) has a very rare conformation in the binding area – an alpha helix. A 
comparison of uncomplexed 10B9 with Der p 1-10B9 complex revealed that the CDR H3 
undergoes a few significant conformational changes upon binding to Der p 1.  
The change is especially well visible for residues Phe100, Leu101, Thr102, Thr103 and 
Asn105 which adopt a well-defined α-helical conformation (one and a half turn alpha-helix as 




  φ (°) ψ (°) φ (°) ψ (°) 
  Arg98 -120.0 87.6 -121.6 92.7 
  Gly99 -131.1 -30.5 -136.9 -6.4 
*  Phe100 -54.6 133.0 -77.6 154.3 
*  Leu101 -58.8 -38.8 -54.7 -40.8 
*  Thr102 -74.0 -28.0 -68.0 -57.0 
*  Thr103 -107.7 -17.0 -64.5 -29.4 
*  Val104 -55.1 -39.7 -70.2 -45.0 
*  Asn105 -79.7 3.4 -66.2 -24.3 
  Tyr106 -114.0 13.9 -123.1 23.8 
  Tyr107 59.9 40.5 52.1 55.9 
  Ala108 -101.4 145.7 -128.6 158.3 
  Met109 -91.0 101.3 -104.0 118.7 
  Asp110 -84.2 -10.8 -83.9 -57.3 
Table X The φ and ψ angles found in CDR H3 in two forms of the Fab of mAb 10B9.  
The phi and psi angles found in CDR H3 in the uncomplexed and complexed form of the Fab of mAb 
10B9. Residues that form a short alpha helix upon binding are indicated with an asterisk. 
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The loop placement during the binding of Der p 1 isshown in Figure 8 and Figure 9. It 
also indicates that the overall conformation of theFab fragment of mAb 10B9 is not 
significantly changed in comparison to the uncomplexed form, but rather all the CDR regions 
are shifted upon binding to Der p 1. There are two salt bridges formed by Der p 1 and 10B9. 
The first is formed by Asp198 and Arg53 of the VL and the second is formed between Glu13 
and Arg98 of the VH. The asymmetric unit contains two copies of Der p 1-10B9 complex and 
fourteen hydrogen bonds have been identified in the first copy and thirteen in the second copy 
of the complex. The hydrogen bonds between Der p 1 and VL of 10B9 involve the following 
residues: Gln18 of Der p 1 and both Gly91 and Asn92 of 10B9 (asparagine forms a hydrogen 
bond only in one of the copies of Der p 1-10B9 complex; Asp198 of Der p 1 and Arg53 (as well 
as Tyr106 of VH) of 10B9; Asn199 of Der p 1 and Arg53 of 10B9. Arg20 was found to form a 
hydrogen bond with Ser30 of the VL, but only in one of the copies of the complex. Thehydrogen 
bonds between Der p 1 and VH of 10B9 involve, respectively, Ala12 and Tyr53, Glu13 and 
Arg98, Asp15 and Tyr107, Asn179 and both Ser31 and Gly32, Gly182 and Ser31, Asp198 and 
Tyr106 (Table VII). Gln181 was found to form a hydrogen bond with Ser31 in only one of the 
copies of the Der p 1-10B9 complex. There is a possibility that two Der p 1 residues form 
cation-π interactions: Gln18 with Tyr107 and Arg17 with Tyr106 of the VH of 10B9, but a 





















Figure 9 The Fab fragment of mAb 10B9 complexed with Der p 1. 
Der p 1 is colored blue. Loop 179-185 of Der p 1 iscolored according to the complexes it comes from: 
Der p 1-10B9 is colored magenta, Der p 1-4C1 is yellow, and Der p 1 in uncomplexed form is orange. 
CDR H3 of the Fab fragment of mAb 10B9 has a very ra e helical form and is colored green and cyan 
in its complexed and uncomplexed form, respectively. The rest of 10B9 is colored grey.  
 
 
7.1.3. Relative location of the epitopes for the mAbs 10B9 and 4C1 on Der p 1 
Even though the epitopes for both 4C1 and 10B9 large y overlap (Table VIII and Table XI), the 
relative position of the antibodies is not shifted, but rather the 4C1 binds to its epitope in a 
position that is "rotated counter-clockwise" by a little more than 90 degrees with respect to the 
position assumed by 10B9 upon binding to its epitope n Der p 1 (Figure 6a and Figure 6b). 
The residues of Der p 1 that participate in hydrogen bonding with both 10B9 and 4C1 are Glu13, 
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Arg17, Gln18 and Asp198. Residues specific to hydrogen bond formation with 4C1 are Arg20 
and Arg156, while Ala12, Asp15, Gln181, Gly182, Tyr185 and Asn199 participate in hydrogen 
bonding with 10B9. A surface exposed tyrosine residue of the Fab fragment of mAb 4C1 forms 
hydrogen bonds with an arginine residue on the surface of the antigen, which is observed at the 
Der p 1 and 4C1 interface (Figure 11a, Figure 11b, Figure 12a, and Figure 12b as well as 
previous work (Chruszcz et al., 2012b)). These bonds are not observed in the Der p 1-10B9 
complex. However hydrogen bonds are present between a surface tyrosine on the antibody and 
an aspartate residue on the surface of Der p 1. Furthermore, such hydrogen bonds are not present 
at the interfaces formed by the Fab fragments of mAb 4C1 or 5H8 and Der p 1. The interface 
between 10B9 and Der p 1 comprises several hydrogen bonds that are formed between serine 
and arginine as well as asparagine/glutamine and glycine. In the 4C1 complex however, the 
interface is formed between arginine, aspartate, serine, or threonine from 4C1 and tyrosine, 
arginine, aspartate, glutamine or glutamate on Der p 1, with the most abundant linkage being 
between tyrosine from 4C1 and arginine from Der p 1 (Table XI, Table XII and Figure 3 of 
















 Der f 1 Der p 1 ASA (Å2) BSA (Å2) 
   Chain A with VH of 4C1 
 Glu14 Glu13 114.3/104.9 49.6/40.9 
 Asp16 Asp15 34.8/27.0 19.1/13.6 
 Arg18 Arg17 69.3/74.4 60.2/62.0 
*  Ser19 Gln18 85.4/127.8 69.1/72.3 
 Arg21 Arg20 179.5/193.6 59.3/92.7 
 Arg157 Arg156 196.5/190.9 60.10/59.2 
 Thr158 Thr157 90.2/89.7 8.5/10.2 
 Ile159 Ile158 31.4/39.6 16.1/16.6 
*  Thr181 Ala180 57.67/39.5 34.1/23.2 
 Tyr186 Tyr185 39.4/35.9 35.8/33.8 
 Asp199 Asp198 63.3/50.7 50.3/45.2 
*  Ser200 Asn199 70.0/101.3 13.1/18.9 
 Tyr202 Tyr201 18.5/18.2 13.7/10.5 
 Tyr204 Tyr203 29.8/27.2 29.8/27.2 
   Chain A with VL of 4C1 
 Arg157 Arg156 196.5/190.9 134.4/127.6 
*  Thr181 Ala180 57.6/39.5 20.2/10.6 
 Gln182 Gln181 190.2/189.0 52.8/50.9 
Table XI The 4C1-binding epitopes on Der p 1 and Der f 1. 
The table presents the amino acids that form the 4C1 binding epitopes on Der p 1 and Der f 1. The 
differences are indicated with an asterisk. The amino acids with buried surface area that were calculated 














4C1 ASA (Å2) BSA (Å2) 
VH Chain D 
Thr30 62.4/62.2 8.2/16.4 
Ser31 70.3/69.3 19.9/30.5 
Asp32 44.3/36.0 23.4/16.4 
Tyr54 66.0/64.7 53.6/53.4 
Ser55 75.0/80.5 30.4/22.9 
Tyr102 152.1/151.0 103.0/99.8 
Arg103 210.3/210.9 89.1/79.1 
Tyr104 160.1/155.1 134.4/131.0 
Pro105 92.1/91.1 80.3/76.3 
Glu106 126.1/119.1 25.1/21.7 
Arg107 102.5/103.8 21.7/18.6 
VL Chain C 
Tyr30 133.2/131.2 41.0/40.6 
Tyr32 76.3/77.3 29.2/24.1 
Arg50 70.1/75.4 10.4/17.8 
Asn52 91.4/- 10.8/- 
Arg53 115.1/124.7 56.4/59.8 
Asp92 52.8/52.9 18.1/18.9 
Table XII The Der p 1 and Der f 1 binding paratopes on the 4C1 antibody. 
The table presents the amino acids that form the Der p 1 (left sides of the ASA and BSA columns) and 
Der f 1 (right sides of the ASA and BSA columns) binding paratopes on the Fab fragment of mAb 4C1. 
The amino acids with buried surface area that were calculated as less than 10 Å2 to the interface were 
omitted. ASA - Accessible Surface Area, BSA - Buried Surface Area 
There is a conformational change of the Der p 1 loop fr m residue 179 to 185 (rmsd 
value of 0.7 Å, where overall rmsd is 0.6 Å) calculated between Der p 1 complexed with 4C1 
and Der p 1 complexed with 10B9. This conformational change however, is not observed 
between uncomplexed Der p 1 and the Der p 1-10B9 complex. This loop provides strong 
interactions with the paratope on the heavy chain of the Fab fragment of mAb 10B9, but it is 
on the edge of the epitope and does not form any substantial interactions with the light chain of 
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the Fab fragment of mAb 4C1 (Figure 9). Therefore, th  conformational change might be 
induced upon binding of water molecules between the 4C1 antibody and Der p 1, which would 
therefore form bridging interactions between Asn179, Ser180 and Tyr186 with Glu106 of CDR 
H3 (as described in previous work (Chruszcz et al., 2012b)). However, this rearrangement is 
located on a peripheral part of the Der p 1-4C1 interface and other variables might contribute 
to the rearrangement. 
7.1.4. Comparison between Der p 1 allergen epitopes for 10B9, 4C1 and 5H8 antibodies 
and the corresponding surface on Der f 1 
The interfaces formed between Der p 1 and 10B9 or De p 1 and 5H8 (both 
species-specific mAb) have larger contact areas than t e interfaces between Der p 1 and 4C1 
and Der f 1 and 4C1 (cross-reactive mAb) (~910 Å2 and ~845 Å2, versus ~745 Å2 and ~760 Å2, 
respectively; calculated by PISA). As mentioned previously, both 10B9 and 5H8 are species 
specific, whereas the 4C1 antibody is cross-reactive between Der p 1 from D. pteronyssinus and 
Der f 1 from D. farinae. The deletion of serine in the 8th position of Der p 1 causes an offset, 
by one residue in the numbering of the amino acid residues between Der p 1 and Der f 1, thus 
Der f 1 numbering of the amino acid residues is used in comparisons of Der f 1 with Der p 1 
for both allergens in this section. 
The QH algorithm was used as the scoring function on structu es superimposed in VMD. 
The calculated QRES values were assigned for every residue and the surface was marked in such 
a way that the amino acids with sidechains that had t e most similar orientation and shape of 
the sidechains are colored blue through white to red (which indicates that the orientation and 
shape of the sidechains were different) (Figure 6d, Figure 6e and Figure 6f). 
The 4C1 antibody is cross-reactive between two dust mite allergens, Der p 1 and Der f 1, 
while 10B9 is specific for Der p 1. In order to explain this observation I compared the residues 
of Der p 1 that form interactions with 10B9 to corresponding residues from Der f 1. The residues 
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that form the 10B9 binding epitope on Der p 1 are partially conserved in Der f 1. In addition to 
the surrounding amino acids not directly involved in the interaction with 10B9, the major 
differences between Der p 1 and Der f 1 in the 10B9 binding epitope include a substitution of 
residues Ser13, Ser19, Ser180, Thr181 and Ser200 in Der f 1 by Ala, Gln, Asn, Ala and Asn 
respectively in Der p 1 (Figure 6e and Figure 10c) which allows for hydrogen bond formation 
between Der p 1 and 10B9 (Table VII). However, a lack of these hydrogen bonds is not the 
major factor preventing the binding of 10B9 to Der f 1. A comparison of the available Der p 1 
and Der f 1 structures reveals that there is a significa t difference in conformation and 
composition of the 179-183 region (Asn-Ala-Gln-Gly-Val) of Der p 1 and corresponding 
180-184 fragment (Ser-Thr-Gln-Gly-Asp) of Der f 1. The different conformations of these 
regions results in a significant shift of the central Gln position, with corresponding Cα atoms 
being shifted by ~3 Å. This shift results in Gln181 in Der p 1 being "parallel" to the allergen's 
surface, where in the case of Der f 1 this residue s "perpendicular" to the allergen’s surface. A 
superposition of the Der p 1-10B9 complex and Der f 1 shows that the "perpendicular" 
conformation of Gln182 in Der f 1 results in a steric clash with Ser31 from the heavy chain of 
the antibody. The density map, which is of good quality around Gln181 allows for the 




Figure 10 The 10B9 (a and c) and 5H8 (b and d) binding epitopes of Der p 1. 
The 10B9 (a and c) and 5H8 (b and d) binding epitopes of Der p 1. The amino acids that form hydrogen 
bonds between Der p 1 and antibodies are colored as follows: Der p 1 – shades of green, 10B9 – purple, 
5H8 – blue. The labels showing residue names and numbers are colored in the same way. The amino 
acid residues in Der f 1 corresponding to residues of Der p 1 epitopes binding 10B9 is shown in c) and
colored purple and 5H8 is shown in d) and colored orange. The cyan colored residues shown in c and d 
come from Der f 1 and are corresponding to residues from Der p 1 labeled purple in c and orange in d. 
The 5H8 binding epitope area on Der p 1 is mostly conserved in Der f 1 (fifteen out of 
twenty four amino acid residues), but there are several differences between them (Table VI). 
Residues Thr54 and Ser94 of Der f 1 are substituted by Gln and Tyr respectively in Der p 1, 
thus making it impossible for Der f 1 to form hydrogen bonds with the Fab fragment of mAb 
5H8 (Figure 10d). Der f 1 amino acid residues Thr54, Glu91, Ser94, Ser109 and Tyr112 are 
substituted respectively by Gln, Gln, Tyr, Ala and Gly residues in Der p 1 respectively, which 
forms a non-conserved spot in the central part of the 5H8 epitope surface area (the white spot 
in the central part of Figure 6f) and therefore changes the shape of the surface of the 5H8 binding 
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epitope (Figure 10d). Some of the amino acids in Der f 1 (Gln86, His111 and Met223) that 
correspond to the 5H8 binding epitope on Der p 1 are substituted (His, Arg and Leu), but in the 
Der p 1-5H8 complex all the interactions are mediated by the main chain atoms for these 
residues and the side chains do not form steric clashes. Therefore these residues should not 
interfere with the possibility of 5H8 binding to Der f 1.  
7.1.5. Analysis of antigen-antibody interactions in complexes reported in PDB  
The expected frequency of amino acids on the surface of proteins was calculated as 
described in Materials and Methods section and is available in Table XIII. 
Amino acid 
A R N D C Q E G H I 




L K M F P S T W Y V 
4.7 5.4 1.6 3.1 7.1 13.1 11.5 2.1 3.7 7.1 
Frequency (%) 
Table XIII The frequency of amino acids on the surface of non-redundant Fab-protein 
and Fab-peptide complexes deposited in PDB (as of 2013). 
 
The methods used to investigate Der p 1 complexes with antibodies made it possible to 
analyze not only these complexes, but all non-redundant complexes of Fab fragments of 
antibodies with proteins or peptides available in the PDB of resolution equal to, or better than, 
3.0 Å (n = 314 as of 2013). The amount of particular amino acids found in the protein-antibody 
or peptide-antibody interfaces are shown in Figure 11g and Figure 11i. However, the observed 
frequency of the amino acids on the surface of the epitopes, in general, is very similar to the 
expected frequency of these amino acids on the surface of proteins from the dataset, with 
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charged or polar residues more frequent, and hydrophobic residues less frequent. Serine and 
threonine are the exception, however, with their occurrence being essentially two times less 
frequent in epitopes than in other parts of the surface of proteins from the dataset. Glutamine 
residues in the epitopes are approximately one third more frequent than expected. The observed 
frequency of the amino acids in the paratopes differ significantly from the expected frequency, 
with tyrosine being six times more frequent and tryptophan being three times more frequent in 
the paratope interfaces than on the surface of proteins from the dataset (Table XIV).  
The observed value of serine frequency in the paratopes of Fab-protein complexes is 
almost equal to the expected serine frequency on the protein’s surface (Table XIV). This 
frequency of serine is not observed in the paratopes f the antibodies interacting with peptides 
and is half of the expected value (Figure 11j and Table XIV). Among charged amino acids, only 
arginine and histidine are more frequent in the paratopes than expected on the surface. The 
frequency of lysine is lower than expected for protein-antibody complexes or almost equal to 














  Antigens Antibodies 
       Interface 
 
amino acids 
proteins peptides Der p 1 antibodies 10B9 5H8 4C1 
antibodies 10B9 5H8 4C1 proteins peptides Der p 1 
A 0.8 1.2 2.0 1.0 2.0 0.4 0.6 0.5 0.0 0.0 
R 1.8 1.6 6.0 4.0 6.0 1.6 1.6 3.0 2.0 8.0 
N 1.3 0.7 2.0 2.0 1.0 1.3 1.3 2.0 0.0 0.0 
D 1.4 1.2 3.0 0.0 4.0 1.6 1.6 0.0 3.0 2.0 
C 2.0 4.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 
Q 1.4 1.8 2.5 4.0 4.0 0.5 0.5 0.0 1.0 0.0 
E 2.0 1.4 2.0 0.0 2.0 1.1 1.2 0.0 0.0 2.0 
G 0.9 0.9 0.7 0.7 0.0 0.9 0.8 1.0 2.7 0.0 
H 2.5 1.8 2.0 0.0 0.0 1.9 2.5 0.0 0.0 0.0 
I 1.4 1.4 0.0 2.0 2.0 0.6 0.9 0.0 0.0 0.0 
L 1.1 1.7 0.0 2.0 0.0 0.6 1.1 1.0 0.5 0.0 
K 1.5 1.3 0.0 0.0 0.0 0.4 0.6 0.0 1.0 0.0 
M 1.2 1.3 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.0 
F 1.0 1.0 0.0 2.0 0.0 1.3 1.6 2.0 0.0 0.0 
P 0.8 0.9 0.0 0.0 0.0 0.3 0.3 0.5 0.0 1.0 
S 0.5 0.5 0.4 0.8 0.0 1.0 0.5 1.4 0.4 1.0 
T 0.4 0.4 0.0 0.0 0.7 0.5 0.5 0.8 1.2 0.5 
W 1.0 1.9 0.0 0.0 0.0 2.9 2.9 0.0 2.0 0.0 
Y 1.1 0.8 5.0 6.0 5.0 5.4 5.2 10.0 4.5 10.0 
V 0.6 0.7 0.0 0.0 0.0 0.3 0.4 1.0 0.0 0.0 
Table XIV The ratio between the observed and the expected amino acid residues 
occurrences in the interfaces between the antigens and the antibodies.  
Ratio was calculated from a frequency of occurrences of a particular amino acid residue in all surfaces 
of non-redundant Fab-protein or Fab-peptide complexes available in the pdbaa NCBI’s BLAST database 





Figure 11 The amino acids found in the Der p 1-antibody interfaces.  
Each plot shows the distribution of residues in the binding surface. The epitopes are shown in a), c), e), 
g) and i), the paratopes are shown in b), d), f), h) and j). The number of residues found in the given 
interface is colored red and expected number of residu  (based on the frequency of the amino acids 
found on the surfaces of protein-Fab complexes from the dataset used) is colored yellow. 
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7.1.6. Amino acid composition of the interface of the complexes of Der p 1 with antibodies 
The interface area of Der p 1 complexed with the Fab fr gments of mAb 4C1, 10B9 or 
5H8 (Figure 11 and Figure 12) is composed of almost every charged or polar amino acid residue 
(tyrosine, threonine, arginine, serine, glutamine, aspartate, glutamate and aspartate). However, 
hydrophobic amino acids like leucine and isoleucine are also present. The amino acids that form 
the interface and are common between all three antibodies include tyrosine, arginine, threonine 
and serine. Tyrosine is one of the main amino acids that contribute the most surface area to the 
interfaces in both the epitopes of Der p 1 and the paratopes of the antibodies. The number of 
tyrosines is approximately five (5H8) to ten times (10B9 and 4C1) higher in paratopes than the 
average tyrosine frequency on protein surfaces of Fab-protein and Fab-peptide complexes 
(Table XIV). Arginine is significantly more abundant in the epitopes of Der p 1 and the 
paratopes of all three antibodies. In the paratope of the Fab fragment of mAb 4C1, arginine is 
eight times more frequent than it is on protein surfaces Fab-protein and Fab-peptide complexes 
(Table XIV). The interface area on the Der p 1 epitopes contains a significantly higher 
frequency of arginine, aspartate, glutamate and glutamine than the general frequency of these 
amino acids on the surface of the proteins from the dataset. Arginine is four to six times more 
frequent, aspartate is three to four times more frequent, glutamate is two times more frequent 
and glutamine is two and a half to four times more frequent than what is expected. Asparagine, 
despite the physicochemical similarity to glutamine, is only present in the paratope of the 4C1 
antibody in twice the expected frequency, and is absent in the 10B9 and 5H8 paratopes. A rather 
unusual observation, in comparison to other antibodies, is that the paratope of the 4C1 antibody 
contains eight times more arginine than the usual arginine frequency on protein surfaces, and it 
is much higher than the general arginine content in the paratopes, as well as in the paratopes of 
10B9 and 5H8 (Table XIV). The hydrogen bonds formed b tween glycines of the Fab fragment 
of mAb 5H8 or the Fab fragment of mAb 10B9 and the Der p 1 allergen are quite common in 
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comparison to the hydrogen bonds formed between all antibodies and all proteins or peptides 
(Figure 7). The differences between amino acids involved in hydrogen bonds between the 
paratopes of the Fab fragments of monoclonal antibodies 4C1, 10B9 and 5H8 and Der p 1 
allergen are significant. Most of the hydrogen bonds in the paratope of 10B9 are formed by 
serine with arginine, asparagine, glutamine or glycine and by tyrosine with alanine or aspartate 
on Der p 1 (Figure 7a). The hydrogen bonds are formed on the 5H8 paratope by aspartate with 
arginine, glutamine or glycine; by glutamine with arginine or asparagine and by tyrosine with 
serine or arginine on the surface of Der p 1 (Figure 7b). A quite rare hydrogen bonding 
interactions can be observed at the Der p 1 epitope and 5H8 paratope interface. Namely, the 
hydrogen bonds are formed between the mainchain atoms of Ile83 and Ile113 of Der p 1 and 
sidechain of Arg101 from 5H8. Additionally, Ile113 from Der p 1 and Asp103 from 5H8 also 
form hydrogen bonds. Surprisingly, there are also not common hydrogen bonds at the interface 
between Der p 1 and 5H8 - formed between glutamines from Der p 1 and arginines and 
aspartates from 5H8 antibody. 
The amino acid composition of the Der p 1 epitopes that bind to the Fab of mAb 10B9, 
5H8 and 4C1, does not contain all of the standard amino acids. The amino acids that are missing 
or underrepresented are mostly non-polar, however, some polar or charged amino acids may 
not be present in the every epitope. Aspartate and glutamate are not present in the 5H8 binding 
epitope, but very common in the 4C1 and 10B9 binding epitopes. Serine is absent in the 4C1 
binding epitope, but present in other epitopes. The4C1 binding epitope contains threonine 
which is absent in both 5H8 and 10B9 binding epitopes. Valine and lysine are absent in all of 
the three epitopes. Alanine is overrepresented in the 4C1 and 10B9 binding epitopes and is 
present in equal amount to the expected value in the 5H8 binding epitope on Der p 1. The 
content of isoleucine, despite being a non-polar amino acid, is significantly higher than expected 
in the 4C1 and 5H8 epitopes, but isoleucine is absent in the 10B9 epitope. Even though the 
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Der p 1 epitopes that bind 4C1 and 10B9 mostly overlap, their amino acids composition is 
different. The epitope that binds 10B9 contains glycine and serine in lower than expected 
quantities and histidine in higher than the expected amount. However, it does not contain either 
threonine or isoleucine, both of which are present in the 4C1 binding epitope.  
7.1.7. Analysis of antigen-antibody interactions in complexes reported in PDB - areas 
contributed by particular amino acids 
 Figure 12 shows the area contributed to the interfac s by particular amino acids. The 
amino acids found in the epitopes of proteins and peptides generally contribute more area to the 
interfaces than amino acids found in the paratopes. R idues that contribute the most area to the 
protein-antibody interfaces found in the epitopes are rginine, histidine, lysine, methionine, 
phenylalanine, and tryptophan, while the residues that contribute the most area to the 
protein-antibody interfaces found in the paratopes ar  arginine, methionine, phenylalanine, and 
tryptophan. The amino acids found in the epitopes of the peptide-antibody interfaces contribute 
even more area to the interface as compared to the protein-antibody interface, but this 
observation can be explained by the small size of peptides. In the paratopes of the 
peptide-antibody interfaces, methionine contributes the most area. Curiously, and in contrast 
with the larger area contribution of methionine in all of these interfaces, the observed frequency 
of methionine found in both the epitopes and paratopes is half the expected frequency of 
methionine on the surface of proteins in the dataset, with the exception of methionine found in 




Figure 12 The area contributed to the Der p 1-antibody interface by each amino acid.  
Each plot shows the distribution of the area contribu ed by the each amino acid residue forming an 
interface. The epitopes are shown in a), c), e), g) and i), the paratopes are shown in b), d), f), h) and j). 
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7.1.8. Analysis of the amino acid composition of the complexes of proteins or peptides with 
Fab fragments of monoclonal antibodies 
The comparative analysis of interfaces formed by Der p 1 with the Fab fragments of 
mAb 4C1, 10B9 and 5H8 required an investigation of the content of the interfaces and hydrogen 
bonds formed by all Fab fragments of antibodies complexed with proteins or peptides. The 
analysis of some of the antigen-antibody interfaces properties showed (Figure 11 and Figure 
12) that tyrosine is found over five times more often on the surface of the paratopes than on the 
surface of proteins in general (Table XIV). It strongly suggests the important structural role of 
tyrosine in forming interfaces and its presence in interface areas found in all complexes of Fab 
fragments of antibodies with proteins, peptides or nucleic acids (unpublished data) and it is 
consistent with earlier studies (Koide and Sidhu, 2009). Tryptophan, which shares some of the 
properties of tyrosine, is found to be three times ore frequent on the surface of paratopes than 
on the surface of proteins in general. A higher concentration of aromatic amino acids at the 
binding interfaces is consistent with a previous repo t (Wu et al., 2010). The quantitative 
analysis of the binding interfaces showed that aromtic amino acids found on paratopes tend to 
contribute significantly more surface area to the interfaces than other amino acids found in 
paratopes, with the exception of methionine. Methionine, despite its very low frequency of 
occurrences in antigen-antibody interfaces, usually contributes significant surface area to the 
interface when present. Serine and threonine, despite having polar side chains, are found to be 
two times less frequent in the protein-antibody or peptide-antibody interfaces as in other parts 
of proteins. The observed frequency of serine in the paratopes, however, is almost equal to the 
expected value.  
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7.2. Bla g 4 
7.2.1. Structural analysis of an apo and liganded forms of Bla g 4 
The Bla g 4 allergen is a compact, globular protein hat folds into a typical lipocalin fold 
(Yih et al., 2009), where the core of the protein co tains a β-barrel formed by eight anti-parallel 
strands. A bent α-helix is placed adjacent and on the outside of the β-barrel (Figure 13). 
 
Figure 13 The Bla g 4 allergen with tyramine.  
Cartoon representation of Bla g 4 with α-helices colored red, β-sheets colored yellow and coiled coils 
colored green. 
Two long-range disulfide bonds (Cys10-Cys112 and Cys44-Cys175) that connect the 
central β-barrel with other structural elements have structural role by strengthening the 
compactness of the Bla g 4 structure. The Se-Met derivative and the native forms of the allergen 
crystallized in the same space group with very similar unit cell parameters. Additionally, the 
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Se-Met derivative is an apo form, while the native version of the protein is a ligand bound form 
of the protein. The superimposition of Cα of these structures yields a rmsd value of 0.3 Å. The
most significant differences between apo and native form of Bla g 4 are observed in the 
mainchain conformations of the loop regions between r sidues ranging from 61 to 65 and from 
134 to141. The analysis of the electron density maps for the structure of the native Bla g 4 
revealed the presence of a large continuous section of electron density, which does not 
correspond to any proteinous part of the allergen. The shape of the difference map for this region 
suggests that tyramine, or a similar small molecule, is present in the structure (Figure 14).  
 
Figure 14 Bla g 4 ligand-binding site with bound tyramine shown in purple. 
Tyrosines and aspartate forming the hydrogen bonds with the amine part of tyramine are green. The 
disulfide bonds are beige. The central part of the ligand is located in a hydrophobic cage which is closed 
by small cap hiding the ligand inside of the protein. 
Although the sequence conservation among proteins from lipocalin protein family is 
quite low, their structure is highly conserved (Figure 15). The superimposition of structures of 
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close homologs of the Bla g 4 allergen revealed the s ructural conservation pattern. The β-barrel 
forming the core of the protein is very highly conserved. The conservation of the kinked α-helix 
adjacent to the protein core is divided into two parts and decreases gradually from the 
moderately high conservation to the lack of conservation along the succession of the α-helix. 
The short α-helix and small loop forming the hydrophobic cap, which covers tyramine binding 
site, were not found to be conserved. The N-terminal part of Bla g 4 is not conserved, but it can 
be attributed to the lack of constraints of its lability. 
 
Figure 15 Structural conservation in Bla g 4.  
Two representations of Bla g 4 (surface on the left and cartoon on the right side). The color scale 
represents mapping of QRES values onto the structure, where red represents no structural conservation 
and the blue represents conserved regions. Tyramine is colored in magenta. QRES can assume values 
from 0 to 1. 
7.2.2. Sequence analysis 
The sequence clustering was done using CLANS, based on a variant of the Fruchterman 
and Reingold graph layout algorithm representing sequence pairwise similarities and groups of 
the similar sequences are divided into the color-coded clusters (Figure 16). The sequences from 
the brown cluster almost exclusively belong to one f the two PFAM families (Lipocalin and 
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Lipocalin-like—PF00061 and PF08212) and are mixed with each other. The Bla g 4 allergen 
belongs to this cluster as well as its closest allergenic homolog – the Per a 4 allergen, both of 
which come from two different species of cockroaches. This cluster contains subclusters 
designated with roman numerals. Subcluster I contains chloroplastic lipocalins. Plasma retinol 
binding protein from various Vertebrata mainly from Canis lupus familiaris, Mus musculus, 
Rattus norvegicus and Homo sapiens are contained within cluster II. Several isoforms of the 
Bla g 4 allergen are found in the small cluster marked as ‘III’. The Bla g 4 allergen, despite 
being classified by PFAM as part of the Triabin protein family, lies closer to Lipocalin protein 
family than to the Triabin protein family. Subcluster IV contains uncharacterized proteins from 
Insecta. Subcluster V is the largest subcluster and is the most diverse of all the other clusters. 
The known protein structures contained within this cluster provide a good representation of the 
structural diversity that can be used for structural studies. The most notable structures are human 
apolipoprotein D complexed with progesterone (PDB codes: 2HZQ, 2HZR), a subunit of 
crustacyanin-A2 (PDB code: 1GKA), apocrustacyanin C2 (PDB code: 1S2P), lipocalin 
complexed with fluorescein (PDB code: 1N0S), insecticyanin-A (PDB code: 1Z24), and Per a 4 
allergen from cockroach (PDB code: 3EBW). The other proteins within this subcluster are 
classified as apolipoprotein D, chlorophyllide A binding protein, bilin binding protein, 
bombyrin, and biliverdin binding protein. The cluster marked with light green contains only 
one protein with a known structure - bacterial lipocalin (PDB code: 1QWD). Inside this cluster 
one can find outer membrane lipoproteins Blc, lipocalin-like and lipoprotein-like proteins from 
the Lipocalin-like PFAM protein family (PF08212) and almost all of those sequences are from 
various bacterial strains. The cyan cluster contains proteins similar to milk proteins from two 
cockroach species Diploptera punctata and Rhyparobia maderae. Various proteins from 
Drosophila sp. are located within the yellow cluster. The navy-blue cluster contains mammalian 
Alpha-1 acid glycoproteins. The cluster marked in green contains lipocalins, retinoic 
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acid-binding proteins, prostaglandin-D synthetases, siderocalins, prostaglandin isomerases, 
neutrophil gelatinases and Alpha-1 microglobulins. Several of the proteins from this cluster 
have their structures determined. These are human lipocalin 15 (PDB code: 2XST), human 
lipocalin 2 (PDB code: 3DSZ, 3BX7, 3BX8, 3DTQ), epidymal retinoic acid-binding protein 
(PDB codes: 1EPA, 1EPB), Human Complement Protein C8alpha (PDB code: 2RD7), 
siderocalin (PDB code: 3S26, 3SAO), lipocalin-type prostaglandin D synthase (PDB codes: 
2CZT, 2CZU, 2RQ0, 2WWP), lipocalin 12 (PDB code:2L5P), and alpha-1-microglobulin (PDB 
code: 3QKG). The cluster marked in orange contains mammalian β-lactoglobulins, major 
urinary proteins, salivary lipocalins, and odorant-binding proteins. Furthermore, this cluster 
contains the largest number of determined protein structures (PDB codes: 1GM6, 2L9C, 1EXS, 
2R73, 2R74, 2RA6, 1XKI, 3EYC, 2A2G, 2A2U, 1EW3, 1I04, 1I05, 1I06, 3L4R, 1DZJ, 1DZK, 
1DZM, 1DZP, 1E00, 1E02, 1E06, 1HQP, 1YUP, and 2HLV). Almost all protein sequences 
from the green and orange cluster are from the Lipocalin PFAM protein family (PF00061). The 
small purple cluster in the top left corner of Figure 16 contains violaxanthin de-epoxidases from 
Arabidopsis thaliana (PDB codes: 3CQN and 3CQR) from plants and bacteria. The pink cluster 
contains sequences from the Triabin PFAM protein family (PF03973). This cluster comprises 
proteins like nitrophorin, thrombin inhibitor or amine binding protein (PDB codes: 1PM1, 
2ALL, 2AMM, 1SXX, 1SY2, 1AVG, 1EUO, 1PEE, 1T68, 2A3F, 2ACP, 2AH7, 2AL0, 2HYS, 
2GTF, 4GE1, and 4GET) and salivary lipocalins. Despit  the PFAM classification, which 
includes Bla g 4 into the Triabin family, this allerg n differs enough from this protein family to 








































































































































































































































































































































































7.2.3. Evolutionary analysis 
All allergen sequences were extracted from the dataset used for sequence analysis in 
this work. Redundancy was removed and extracted allrgen sequences were used to compute a 
Maximum Likelihood phylogenetic tree (Figure 17). The similarity between the sequences is 
reflected by their branch length. The β-lactoglobulin protein family (Bos d 5, Bub b BLG, Ran 
t BLG, Cap h BLG, Ovi a BLG) is represented by the largest and the most closely related group. 
The level of similarity between the β-lactoglobulin proteins found in the dataset is so high that, 
it is almost impossible to distinguish between them on this tree and it is not necessary for this 
work. The horse β-lactoglobulins (Equ c BLG 1 and Equ c BLG 2), however, are placed further 
from the large β-lactoglobulin group. Two groups of allergens are equally distant from 
β-lactoglobulin group and from each other. The first one is the dog lipocalin allergen (Can f 2) 
and the second one consist of a small group containi g lipocalins from human, dog, and cat 
(Hum s TL, Can f 1, Fel d 7). Another closely relatd and large group is formed by the major 
urinary proteins from rat (Rat n 1) and mouse (Mus m 1) and lipocalins from dog, cat, and horse 
(Can f 6, Fel d 4, Equ c 1). The group containing the major urinary protein group consists of 
the lipocalin allergens from guinea pig and bovine (Cav p 2, Cav p 3 and Bos d 2). The group 
with the shortest distance to the Bla g 4 is formed by the protein from the procalin protein family 
- Tria p 4 from California kissing bug (Triatoma protracta) and it is the closest homolog to both 





Figure 17 Maximum likelihood unrooted tree of Bla g 4 allergenic homologs.  
The length of the branches (red) reflects the similarity between the sequences. The numbers near the 
nodes show the bootstrap values for that particular node. The bootstrap values below 50 are not shown. 
The last group consist of the Bla g 4 and Per a 4 allergens, which are the closest 
homologs. However, there are several differences between them and Tria p 1, despite being the 
closest allergen to Bla g 4 and Per a 4. The sequence alignment of these allergens (Figure 18) 
shows not all amino acids involved in tyramine binding present in Bla g 4 are conserved, even 
in those that are the most closely related. Tria p 1 belongs to one of the lipocalin protein 
subfamily – procalins and Asp47 and Tyr85 (from Blag 4) are substituted with Asn45 and 
Phe89, respectively. Since the data were not sufficient for preparing a reliable sequence 





Figure 18 Alignment of allergens found in sequence dataset.  
Amino acids involved in binding of tyramine are colored green (identical to amino acids in Bla g 4 are 
colored light green; similar are colored dark green). Amino acids involved in forming the hydrophobic 




7.3. Alt a 1 
7.3.1. Structural analysis 
The Alt a 1 allergen crystallized in tetragonal system and I4122 space group with one 
protein chain in the asymmetric unit. Residues 28-157 of the Alt a 1 sequence were fit into the 
electron density. The protein is formed by eleven β-strands that wrap around forming a β-barrel 
(Figure 19). Pro125 breaks the seventh strand into two fragments - β7a (residues 116-123) and 
β7b (residues 126-130). An eight strand is broken into three subunits by a β-bulge and Leu150 
- β8a (residues 138-142), β8b (residues 146-149), and β8c (residues 151-153). Despite the fact 
that β8b and β8c are successive to each other, they belong to the different sheets forming the 




Figure 19 Overall structure of Alt a 1.  
Two representations of Alt a 1: (a) the topology diagram and (b) cartoon. β-strands are labelled and 
colored in rainbow scale for both representations from N-terminus in blue to C-terminus in red. Disulfide 
bonds and Cys30 are represented as blue lines. 
All of the five cysteine residues are involved in forming of the disulfide bridges. The 
bridge formed by Cys128-Cys140 joins two close β-strands - β7b and β8a. The strand β3 is 
linked to the β4 strand by the Cys74-Cys89 bridge. This bridge could be described as a clamp 
holding both barrel-forming β-sheets. Two symmetry related Alt a 1 chains are covalently 
linked with two Cys30, one coming from each chain. This stabilizes the dimer form of the 
protein (Figure 20), however, Cys30 is not conserved in all homologous sequences (Figure 23). 
The hydrophobic residues fill the center of the barrel and there is no inner cavity that could be 




Figure 20 The Alt a 1 dimer and small molecular compounds. 
The dimer is shown with molecular compounds (explanatio  in text) as a) cartoon and b) molecular 
surface. Alt a 1 molecules are colored green and cyan. Disulfide bridges are shown in orange. Disulfide 
bridge between Cys30 of two Alt a 1 monomers is orange. There are two locations of compounds in the 
Alt a 1 structure c) containing 4-HTP and 8-ACA and d) containing two copies of 4-HTP. 
The dimer is stabilized by the disulfide bridge and by a mixture of hydrophobic and 
hydrophilic interactions. Both N-terminal and C-terminal regions of the protein participate in 
dimer formation (Figure 20). Several of the residues (Asp100, Arg103, Thr121, Thr123, 
Thr149, Leu150, and Thr152) form hydrogen bonds betwe n the protein chains, forming the 
dimeric assembly. The dimer interface is large, having an area of 1345Å2 (Chruszcz et al., 
2012a). 
The surface of Alt a 1 contains a substantial number of acidic residues (12 Asp and 5 
Glu) relative to the number of basic residues (3 Arg, 9 Lys, and 1 His), resulting in a theoretical 
pI of 4.7 (for surface residues). The acidic amino acids are located on the surface of the Alt a 1 
dimer (Figure 21), where they form three negatively charged patches. The sequence of the Alt 
a 1 allergen (theoretical pI = 4.75) contains more of basic amino acids (4 Arg, 9 Lys, and 1 His) 
than acidic residues (12 Asp and 6 Glu). Possibly the negatively charged patches take part in 
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the binding of the ligand and the dimerization process. However, there is nothing bound to the 
third patch, so its role is not clear. Moreover, the different structure of Alt a 1 deposited in PDB 
(PDB code: 4AUD) does not contain ligand. 
 
Figure 21 Surface of the Alt a 1 dimer with mapped electrostatic charges.  
The dimer of Alt a 1 is shown from different angles with one of the monomers shown as semi-transparent 
cartoon to highlight the charges in the dimer interface area. The ligand bound (2,5,6-triaminopyrimidin-
4-ol) is shown as spheres. The electrostatic charges ar  colored from red (negative charge), through 






Figure 22 Superimposition of two dimers of Alt a 1. 
First dimer is recreated from 3V0R (original chain is shown in green and recreated dimeric chain is 
shown in cyan), second dimer is 4AUD (shown in red). The dimers are superimposed with one of the 
Alt a 1 monomers from 3V0R structure (green).  
Another structure of Alt a 1 (PDB code: 4AUD) is alo dimeric (Figure 22). However, 
it does not have Cys30 in the structure, as it is missing from 4AUD sequence. Overall the dimer 
formed by Alt a 1 in 4AUD structure is almost identical to the other Alt a1 structure, with the 
exception of a few degrees difference of the angle formed between the two Alt a 1 chains in 
each structure. No other structures with a significant degree of similarity to Alt a 1 were 
identified by either DALI or FATCAT. The highest similarity structures identified by these 
programs yielded values of rmsd around 3 Å and mainly residues forming the β-barrel have 
been aligned. The aligned fragments had their sequence identity ranging from 5 to 12% in most 
cases.  
7.3.2. Evolutionary and sequence analysis 
All sequences obtained from exhaustive searches against the nr database (NCBI 
Resource Coordinators, 2013) contained only fungal proteins from Dothideomycetes (where 
Alternaria alternata species is classified) and Sordariomycetes classes that belong to 
Pezizomycotina subphylum. Both Dothideomycetes and Sordariomycetes are classified as 
Leotiomyceta (Schoch et al., 2009). The dataset was then prepared and narrowed to include 




Organism Identity (%) Similarity (%) 
Alternaria brassicicola (gi: 20279107)*** 89.6 98.7 
Crivellia papaveracea (gi: 307147764)*** 82.1 95.9 
Alternaria brassicae (gi: 49476533)*** 81.8 95.6 
Embellisia telluster (gi: 49476565)*** 81.6 96.3 
Pleospora tarda (gi: 74588233)*** 81.0 94.2 
Alternaria argyranthemi (gi: 49476475)*** 80.6 93.5 
Alternaria species CID76 (gi: 148792960)*** 79.9 97.1 
Embellisia proteae (gi: 209363449)*** 70.1 92.7 
Lewia species CID245 (gi: 148357931)*** 66.9 84.5 
Leptosphaeria maculans (gi: 312213528)*** 63.2 85.8 
Mycosphaerella graminicola (gi: 339470688)** 40.9 71.3 
Pyrenophora teres f. teres (gi: 330921398)** 39.3 74.2 
Myceliophthora thermophila (gi: 347012821)* 32.4 55.3 
Verticillium dahliae (gi: 321271123)* 31.9 60.1 
Phaeosphaeria nodorum (gi: 169594938)* 31.7 56.1 
Mycosphaerella graminicola (gi: 339469016)** 31.2 58.1 
Chaetomium globosum (gi: 116179392)* 31.1 60.5 
Pyrenophora tritici-repentis (gi: 189202924)* 30.1 56.9 
Magnaporthe oryzae (gi: 39970423)* 29.0 60.0 
Glomerella graminicola (gi: 310797708)* 27.0 58.3 
Glomerella graminicola (gi: 310798150)* 25.6 56.9 
Gibberella zeae (gi: 46114386)* 24.7 55.1 
Table XV Sequence identity and sequence similarity to Alt a 1 (gi: 14423645).  
Sequences are sorted by identity. Names of the mostsimilar sequences are marked with *** (they are 
shown in black on Figure 23 and Figure 24), sequences with lower degree of similarity are marked with 
** (they are shown in grey on Figure 23 and Figure 24), and names of the least similar sequences are 
marked with * and are shown in brown on Figure 23 and Figure 24.  
 
Cysteines corresponding to Cys30 of Alt a 1 is only conserved among the homologs 
closest to Alt a 1, while Cys74, Cys89, Cys128, andCys140 are conserved among almost all 
sequences with the exception of one (gi: 307147764), which is of shorter length (Figure 23). 
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This is represented on a tree computed from the alignment of selected Alt a 1 homologs and a 




































































































































































































































































































































































































































































The Pfam database (Punta et al., 2012) (version 28.0) classifies the Alt a 1 allergen in 
Pfam-A since June 2015 as the AltA1 family (PF16541). The AltA1 Pfam family contains 461 
sequences from 301 species from the Fungi kingdom (mostly from Alternaria, Ulocladium, 
Embellisia, Nymbya, Lewia genera). The sequences of full length from AltA1 Pfam family were 
downloaded and aligned by MAFFT (Katoh and Standley, 2013) using the L-INS-I option. The 
alignment shows that four cysteines forming the twodisulfide bridges (Cys74 with Cys89 and 
Cys128 with Cys140) are conserved in all sequences, but Cys30 is not included in this Pfam 
family and is not conserved. 
The Allergome database (Mari et al., 2009) lists 174 Alt a 1-related allergens. Each of 
these comes from different fungal species and is available in UniProt database (The UniProt 
Consortium, 2014). The sequence alignment computed by MAFFT (Katoh and Standley, 2013) 
using the L-INS-I option to increase accuracy shows, that Cys30 taking part in dimerization is 
conserved in all but three of the sequences. In one cas  the sequence is missing the N-terminus 
(Alternaria citri; Alt it 1 allergen), in one case there is deletion n Cys30 area (Alternaria 
nobilis; Alt no 1 allergen) and in one case cysteine is substituted by arginine (Ulocladium dauci; 
Ulo da 1 allergen). Cysteines forming the first of two disulfide bridges, Cys74 and Cys89, are 
conserved in all sequences. The second disulfide bridge formed by Cys128 and Cys140 is 
conserved in almost all sequences, but eight, which do not have full length. The sequence from 
Alternaria ascaloniae (Alt as 1 allergen), does not have either Cys128 or Cys140, resulting 
from a truncation. The other seven sequences (Alternaria iranica – Alt ir 1; Alternaria citri – 
Alt it 1; Alternaria porri – Alt po 1; Alternaria prasonis – Alt ra 1; Alternaria vanuatuensis – 
Alt vn 1; Alternaria penicillata – Cri pa 1; Sinomyces fusoideus – Sin fu 1) has only Cys140. 
The sequence conservation among the whole AltA1 protein family is relatively high 
with the structure mostly invariant with the exception of β7a, β8a and β8c β-strands and some 
loops (Thr33-Asp37, Gln77-Leu81, Ala130-Phe138, and Val112-Ile116) being not well 
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conserved. The conserved patches on the surface of Alt a 1 have been identified (Figure 25) and 
they are possible targets for the design of the cross- eactive antibodies directed against the many 
members of the protein family to which Alt a 1 belongs. Despite the conservation of Cys74, 
Cys89, Cys128 and Cys140 among the whole group, the amino acids involved in forming the 
dimerization interface (Ile148-Ser157) are not well conserved. The amino acids present in the 
previously described IgE epitopes (Kurup et al., 2003) are well conserved for the peptides 
(Lys41-Pro50 and Tyr54-Lys63) that caused strong reaction. The amino acids present in the 
peptides (Tyr87-Asp96 and Val119-Cys128) that showed ak IgE binding are less conserved 




Figure 25 Sequence conservation among close Alt a 1 homologs mapped on Alt a 1.  
Each monomer of Alt a 1 dimer is in different representation – first is shown as surface, second as 
cartoon. Color scale, based on Consurf (Ashkenazy et al., 2010; Celniker et al., 2013) scores, ranges 




8.1. Der p 1 
The cross-reacting epitopes of Der p 1 and Der f 1 are targeted by most human IgE 
antibodies (>80%) (Arruda et al., 1991; Heymann et al., 1986). Thus, most species-specific 
mAb developed against Der p 1 did not inhibit IgE binding to this allergen. The species-specific 
monoclonal antibodies 10B9 and 5H8, as well as the cross-reactive mAb 4C1, partially inhibited 
IgE antibody binding to Der p 1 (Chapman and Platts-Mills, 1980; Thomas et al., 2010). The 
three epitopes of these mAbs, identified on Der p 1 by X-ray crystallography, provide the basis 
for ongoing analysis of antigenic determinants involved in IgE antibody binding (Chapman et 
al., 1987, 1984; Heymann et al., 1986).  
The unique alpha-helical loop in CDR-H3 of 10B9 antibody, which fits into a cavity on 
the epitope on Der p 1’s surface, is formed by a conformational change that occurs upon binding 
to Der p 1. An alpha-helix is found in the CDR-H3 region of antibodies in less than twenty out 
of approximately one thousand of monoclonal antibody structures reported in the PDB as of 
2014. This form of secondary structure in CDR-H3 is very rare, and its role has been described 
in only a few cases as inhibitory (it is mimicking the structure of other protein and competes 
for binding site) (Dong et al., 2010), as affecting antigen recognition (Blech et al., 2012; Bulek 
et al., 2012), or it can form a tentacle which provides a large interaction surface for antigen 
binding (Blech et al., 2012). In almost all other structures of Fab fragments of antibodies, the 
CDR-H3 forms a random coil loop without distinctive characteristics. The CDR-H3 loop of 
10B9 can assume multiple functions that can be explained as affecting recognition of Der p 1; 
providing the structural backbone for the formation of the Der p 1-10B9 interface; stabilization 
of Der p 1-10B9 interface by increasing the size of the paratope area and participating in 
forming hydrogen bonds. The interaction between 10B9 and Der p 1 is an example of the 
“induced fit” model of protein interactions rather than “lock-and-key”. Considering the 
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“lock-and-key” interaction of Der p 1 with 4C1 antibody described previously (Chruszcz et al., 
2012b), this study shows that both types of antigen-antibody interactions can occur even in a 
similar area of the antigen surface. 
The Der p 1 epitope that binds the 5H8 antibody may be affected by sequence 
polymorphisms in a few sites (Ala108 and Ile113) (Piboonpocanun et al., 2006). However, the 
structural analysis revealed that these amino acids re involved in the interface creation by their 
mainchain atoms and their variance most likely does not interfere with 5H8 binding. Both 10B9 
and 4C1 binding epitopes on Der p 1 do not contain residues associated with sequence 
polymorphisms (Piboonpocanun et al., 2006). A comparison of the mature Der p 1-antibody 
complex structures with the structure of pro-rDer p 1 clearly indicates that the presence of the 
pro-peptide does not interfere with the binding of 4C1, 10B9 and 5H8 Fab fragments to the 
allergen. 
The structural studies of Der p 1 and Der f 1 allergens allowed us to directly compare 
the epitopes that bind the Fab fragments of mAb 4C1, 10B9 or 5H8. Such a comparison provides 
the detailed insight, at the molecular level, about which of the characteristics of these antibodies 
surfaces are responsible for the fact that 10B9 and 5H8 antibodies are Der p 1 specific, while 
4C1 is cross-reactive and binds both Der f 1 and Der p 1 (Chruszcz et al., 2012b). The results 
presented here indicate which of the Der p 1 amino acids involved in binding the 10B9 and 5H8 
antibodies are different between Der p 1 and Der f 1, rendering the latter impossible to bind 
10B9 and 5H8. The residues that were different betwe n the 10B9 and 5H8 binding epitopes 
on Der p 1, and the corresponding surface area of Der f 1, are mostly charged and polar. 
However, there are a few substitutions of the non-plar amino acids like alanine to small polar 
amino acids like threonine and serine, which may affect their attractions with the amino acids 
found in the paratopes of the 10B9 and 5H8 antibodies, and therefore contribute to the species 
specificity. In Der f 1, the number of amino acids that differ from the corresponding residues 
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that form hydrogen bonds between 10B9 or 5H8 and Der p 1 is significant. These substitutions 
apparently contribute to the lack of binding of these two antibodies to the Der f 1 allergen, 
despite a high sequence identity (~75%) and similarity (~83%) between these two allergens at 
surface level. These results indicate that the relativ ly small differences in the allergen surface 
may impair the antibody binding. For example, such changes may involve the presence of a few 
non-conserved residues, which were observed in the cas  of the Der f 1 region that corresponds 
to the 5H8 epitope in Der p 1. However, these differences may be more subtle as it occurs on 
the surface of Der f 1, in the region corresponding to the 10B9 epitope in Der p 1. In this case, 
Der f 1 has amino acids with smaller sidechains than e corresponding amino acids in Der p 1, 
and therefore it is unable to form as many binding interactions with 10B9 as Der p 1. In addition, 
to the "missing" interactions, the conformation of the 180-184 fragment (Ser-Thr-Gln-Gly-Asp) 
in Der f 1 is not compatible with the CDR on 10B9, as the main chain of Gln182 generates a 
steric clash between the allergen and the antibody. 
The amino acid composition of the Der p 1 epitopes for the 4C1, 10B9 and 5H8 
antibodies demonstrates that in general there is little preference of the particular amino acids; 
however, all the polar or charged amino acids are much more frequent than the non-polar ones. 
The surface of the paratope is built from the polar amino acids like tyrosine or serine, possibly 
to increase the steric compatibility and to compensate for the epitope’s charge. In the contrast 
to 10B9 and 5H8, the paratope of the 4C1 antibody has a very high arginine content which, by 
adding a positive charge to the Der p 1 binding paratope, may partially explain its 
cross-reactivity.  
The analysis of the Der p 1 and Der f 1 allergen-antibody complexes prompted to 
investigate all the protein-antibody and the peptide-antibody complexes that have their 
structures determined. A methodology that allows analysis of the properties of the epitopes and 
the paratopes with regards to the relative frequency of the amino acids, the areas of the 
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interactions for the particular amino acids, and the hydrogen bonding interactions has been 
developed. This methodology allows for the generation of several types of the plots highlighting 
the diverse aspects of the epitopes and the paratopes characteristics. The analysis of the amino 
acid composition of all of the antigen-antibody interfaces in the dataset used versus interfaces 
formed by Der p 1 with 10B9, 5H8 and 4C1 (Table IV, Table V, Table VIII, Table IX, Table 
XI, Table XII, Table XIV and Figure 11) indicated that the amino acid composition of the 
Der p 1 epitopes is similar to them. None of the amino acids are significantly overrepresented 
in the epitopes. However, the amino acid composition of the epitopes shows some bias towards 
the polar (with the exception of serine and threonine) and the charged amino acids. Such bias 
is observed for both the proteins and the short pepid s. The observed frequency of serine and 
threonine is half of the expected value, which may be caused by the size of their side chains and 
a significant amount of tyrosines in the paratopes. One could expect such results for the proteins, 
taking into account that the residues forming the epitopes are on their surface, but this trend is 
not so obvious for the peptide-antibodies complexes. The amino acid composition of the 
paratopes is highly biased toward the polar (except of serine and threonine) and the charged 
amino acids with a significant absence of the non-plar amino acids. It is also striking that 
tryptophan and especially tyrosine are significantly overrepresented in the CDRs of the 
antibodies. The special role of tyrosine was already noticed (Koide and Sidhu, 2009) and most 
likely could be explained by the chemical nature of this amino acid residue that allows it to 
participate in many types of the bonding interactions.  
The analysis of the antigen-antibody interfaces revealed a preference for the certain 
amino acids that are involved in forming the hydrogen bonds between the antibodies and the 
antigens. The amino acids that are the most involved in the hydrogen bond formation on the 
surface of the paratopes are tyrosine (22%), serine (14%), aspartate (13%), arginine (10%), and 
asparagine (9%). On the surface of the epitopes, the most hydrogen bonds are formed by 
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arginine (15%), glutamate (11%), aspartate (10%), lysine (10%), serine (9%), and asparagine 
or glutamine (both are 8% each). A closer look at the surface area of the antigen-antibody 
interfaces indicates that the number of amino acids is lower for the antigens and higher for the 
antibodies. The relative area contributed to the int rfaces by particular amino acids, however, 
is quite opposite, higher for the former and lower for the latter. This is consistent with the fact 
that, in general, antibodies must have the possibility to evolve and quickly adjust to recognize 
a wide variety of antigens (clonal selection and affinity maturation). Having several residues in 
the binding site provides a greater flexibility to precisely recognize the different epitopes. It is 
a nature of the immune response and such variability is not needed at the level of the epitopes 
as it is not their role to try and bind to an antibody, but it is the role of the antibody to bind to 
an antigen. Although this might not have the desired response in the case of allergens, the 
antibody is doing what it is supposed to. It may not even be desired in the design of the 
molecules that no longer bind the antibody, as the mutation of just a few residues that contribute 
a large surface area, might be enough to prevent an undesired recognition by the antibodies and 
lead to the design of a molecule usable for immunotherapy.  
There are various methods that currently exist for he prediction of the linear (Hopp and 
Woods, 1981; Parker et al., 1986; Welling et al., 1985) and the conformational (Kulkarni-Kale 
et al., 2005; Lo et al., 2013; Negi and Braun, 2009; Zhang et al., 2012) epitopes. The linear 
epitope prediction algorithms do not provide enough value because most of the epitopes in the 
globular proteins are discontinuous or non-linear and brought together during protein folding 
(Barlow et al., 1986; Thornton et al., 1986). The algorithms used in these methods consider 
various properties of the epitopes like the hydrophilicity scale, the protein secondary structure, 
the protein flexibility, but their accuracy was claimed by the authors at usually around 80%. 
There is no the epitope prediction algorithm that takes into account the surface contributed to 
the interface area by the particular amino acids. The method describing the contribution of the 
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surface area and the preferences in forming hydrogen bonds between the antigens and the 
antibodies may be used alongside the sequences and the structures as an element of creating a 
new epitope prediction tools with the very high prediction accuracy.  
8.2. Bla g 4 
The Bla g 4 allergen is a member of a lipocalin protein family, and similar to other 
members of this family binds small molecule ligands. A re-examination of two crystal forms of 
Bla g 4 resulted in the opening of new possibilities to analyze the function of this allergen. The 
crystallization of Bla g 4 in the apo and native forms can be attributed to different protein 
production protocols. The high resolution of the structure allowed the examination of the 
electron density and indicated that it was tyramine that was bound to Bla g 4 as a ligand. The 
tyramine binding was later verified through both NMR titration and isothermal titration 
calorimetry experiments (Offermann et al., 2014). In addition, both these techniques indicated 
that tyramine and octopamine (Figure 26) are bound by the allergen in a similar manner 
(Offermann et al., 2014). 
 
Figure 26 R-Octopamine (cyan), S-Octopamine (orange) and Tyramine (green). 




The interaction of Bla g 4 and ligand is of dual nature and consist of both hydrogen 
bonds and hydrophobic interactions. The hydroxyl group of Tyr85 and carboxylate of Asp47 
form hydrogen bond with the amine group of tyramine. The third hydrogen bond links the amine 
group to a water molecule bound to Tyr122. Bla g 4 does not form any direct hydrogen bonds 
with the hydroxyl group of tyramine, but does interact with the water molecules that fill part of 
the ligand binding cavity. All water molecules that are in the vicinity of the tyramine's hydroxyl 
group form hydrogen bonds with other waters or main chain atoms of the protein. The 
sidechains of Ile31, Leu39, Trp45, and Tyr122 form a hydrophobic cage that surrounds central 
part of the ligand. The binding site is closed by a cap formed by Tyr42 and Phe92. The binding 
site in the structure of Bla g 4 without the ligand is filled with approximately 12 water 
molecules, some of which are displaced upon the ligand binding. The positions of the water 
molecules that act as bridges between Bla g 4 and tyramine are not substantially changed. The 
conformational change of the residues that forming the hydrophobic cage is minimal with Ile31 
and Asp47 having the small changes in the conformation of the side chains (Offermann et al., 
2014) 
Identification of structures similar to Bla g 4 was performed with DALI (Holm and 
Rosenström, 2010) and FATCAT (Ye and Godzik, 2004). The structure of the Per a 4 allergen 
was found to be the most similar (∼2 Å rmsd) (Offermann et al., 2014). At the value of around 
2 Å rmsd searches with Bla g 4 structure as a query, most of the identified proteins belong to 
the lipocalin family, thus a substantial number of them have structures complexed with small 
molecules, like for example biogenic amine-binding protein from saliva of Rhodnius prolixus 
(PDB code: 4GE1) (Xu et al., 2013). None of the ligands complexed with the identified proteins 
are bound in the same manner as tyramine in Bla g 4. Tyramine is identified as a ligand in only 
two structures in PDB (as of July 2015) with Bla g 4 being one (PDB code 4N7C) and 
Alzheimer's disease drug target BACE-1 (PDB code: 3BRA) being the other (Kuglstatter et al., 
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2008). BACE-1 protein, however, binds tyramine in a vastly different mode than Bla g 4. 
Octopamine can be found in three structures in the PDB (July 2015). Goat lactoperoxidase is 
among the structures in PDB that bind octopamine bids the R-octopamine enantiomer (PDB 
code: 4QJQ) and the binding mode resembles Bla g 4, with octopamine buried inside the 
binding cavity and interacting via hydrogen bonds, hydrophobic forces, and some of the 
interactions are being carried by water molecules. Another protein that binds octopamine is 
human phenylethanolamine N-methyltransfrase (hPNMT) (PDB codes: 3HCA, 3HCE and 
2AN4). PNMT is an adrenaline-synthesizing enzyme and it also binds octopamine in similar 
mode to Bla g 4 – the ligand is buried in the protein, and it interacts with the macromolecule 
through both hydrogen bonds and hydrophobic interacions. Some interactions also involve 
bridging water molecules. Human tyrosyl-DNA phosphodiesterase (Tdp1) is the remaining 
protein that binds octopamine. Both enantiomers of octopamine (PDB codes: 1RG2 and 1RGT) 
or S-octopamine only (PDB codes: 1RGU and 1RH0). Octopamine binding, however, is 
bridged by vanadate in the Tdp1 structures and it is different than in Bla g 4 (Offermann et al., 
2014). 
A comparison of the Bla g 4 and Per a 4 binding sites revealed partial conservation of 
the residues that form the hydrophobic cage (Figure 27). Asp47 and Tyr85, which participate 
in hydrogen bonding with the amide moiety of tyramine are among those conserved residues 
(Figure 14). However, some of the residues in Bla g 4 that directly interact with the ligand are 




Figure 27 Superimposition of Bla g 4 (green) and Per a 4 (cyan) with0 tyramine (purple).  
Both structures are in the cartoon representation. PDB codes: 4N7C (Bla g 4), 3EBW (Per a 4). 
 The simple modelling of binding different ligands is shown in Figure 28 and the results 
(Offermann et al., 2014) suggest that both enantiomers of octopamine can fit into the binding 
cavity in Bla g 4. The results of NMR and ITC experiments support this proposition and suggest 
that Bla g 4 binds octopamine in the same manner as tyr mine with the exception is Tyr96, 
which may form a hydrogen bond with the hydroxyl group of the octopamine. The difference 
between binding of the enantiomers of octopamine is that the hydrogen bond formed between 
O7 of R-octopamine and hydroxyl group of Tyr96 may be stronger that analogous bond formed 
by S-octopamine, as the length of the bond is shorter for R-octopamine (2.7 Å) than for S-
octopamine (3.3 Å). The distance from N8 of both enantiomers of octopamine to the hydroxyl 






















































































































































Bla g 4 and Per a 4 are cross-reactive despite the fact that their sequence identity is very 
low (21%). One explanation for this phenomenon assumes that a common IgE epitope exists 
for both proteins. In order to investigate the existence of such an epitope, structures of both 
allergens were superposed and continuous surface pat hes containing identical and similar 
amino acids were identified (Figure 29). In addition the previously reported studies of Bla g 4 
and Per a 4 mutants were used to determine whether some of the conserved regions may at least 
partially overlap with IgE epitopes (Yih et al., 2009). 
 
 
Figure 29 Similarity between the Bla g 4 and Per a 4 allergens.  
Bla g 4 position is identical in columns. The upper row show Bla g 4 in cartoon representation, in the 
lower row Bla g 4 is shown as surface. Residues that are identical in Bla g 4 and Per a 4 are highlighted 
in blue while similar residues are highlighted in orange. 
The comparison of the Bla g 4 and Per a 4 structures reveal the presence of three surface 
patches that contain residues that are conserved in t rms of sequence and structure. The first of 
these patches (P1) is composed of Gly27, Ser28, Arg48, Phe49, Leu55, Val56, and Gly72 
(sequence numbering for Bla g 4; identical residues ar  in bold). The second patch (P2) contains 
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residues Asp21, Arg24, Thr101, Asp102, Tyr103, Glu104, and Tyr106, while the third patch 
(P3) is composed of Thr35, Lys154, Glu158, Glu159, Leu166, Glu169, and Asp170. 
Solvent-accessible surface areas for these patches are 270 Å2, 360 Å2, and 530 Å2, 
respectively. These three regions are potential candid tes for being conformational IgE epitopes 
for both allergens. A large portion of the second region (P2) is composed of residues identical 
or similar between Per a 4 and Bla g 4. The patch P2 can be considered as a potential cross-
reactive antibody binding site or a part of a larger IgE-binding epitope. The sequence 
polymorphism identified in Bla g 4 (Jeong et al., 2009, 2008) in patches P1 (Ser28) and P2 
(Arg24) contributed to increased similarity between Bla g 4 and Per a 4 in corresponding areas. 
Three linear regions containing antibody binding sites were identified by studying IgE binding 
with five overlapping peptide fragments (E1: aa1-100, E2: aa 34-77, E3: aa 74-117, E4: aa 114-
156, E5: aa 153-182) (Shin et al., 2009). Two of the peptides (E1 and E2) correspond to patches 
P1 and P2. The major IgE-binding region is located t residues 118-152 and it is not overlapping 
with either of patches similar between Bla g 4 and Per a 4. The result of analysis of IgE binding 
the residues forming the patch P2 suggests in some cases their role in cross-reactivity. The role 
of the residues forming patch P3 in cross-reactivity between Bla g 4 and Per a 4 have not yet 
been analyzed. 
The comparison of Bla g 4 to its closest documented allergenic homolog, Per a 4, 
suggests that the ligands bound by them are most likely different ligands or have different 
modes for tyramine or octopamine binding. The amine group of tyramine forms hydrogen bonds 
with two of Bla g 4 residues - Asp47 and Tyr85. More ver, these residues are also conserved 
in Per a 4. This fact suggests the possibility of the presence of an amine group in the 
physiological ligand bound by Per a 4 and its overall tyramine similarity. The binding of 
octopamine by Bla g 4 most probably involves Tyr96, which is also conserved in Per a 4. 
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Several studies regarding the role of tyramine or octopamine in reproduction of insects 
have been conducted (Lange, 2009). Tyramine was found to be present in oviducts (Donini and 
Lange, 2004) and spermatheca of locust (da Silva and L ge, 2008; Lange, 2009). Tyramine 
also suppresses pheromone production after mating in Bombyx mori (Hirashima et al., 2007), 
and octopamine had no effect on this process. It ishighly possible and in consensus with 
previous findings that tyramine or octopamine or one f them is the physiological ligand of 
Bla g 4. 
8.3. Alt a 1 
Alt a 1 and its homologs are unique to Fungi and characteristic for mostly 
Dothideomycetes and Sordariomycetes classes. The uniqueness of Alt a 1 is not only limited to 
its sequence, but the structure it forms does not have homologs in the PDB (July 2015) and 
Pfam protein family was named after it. The intramolecular pattern of the disulfides bonds are 
observed in all known homologs of Alt a 1 and presented in the dataset of selected 
representatives in the Figure 23.  
It was observed that the Alt a 1 allergen is localized exclusively in the cell wall of 
Alternaria spores, but not in the cytoplasm (Twaroch et al., 2012). The airborne fungal spores 
are extremely resistant against antagonistic conditions. The IgE epitopes of Alt a 1 can resist 
heat treatment of 95°C (Twaroch et al., 2012). This ob ervation is consistent with the previous 
report speculating that Alt a 1 is involved in spore germination (Mitakakis et al., 2001). The 
presence of disulfide bridges increase the stability of Alt a 1 and its homologs. The biological 
function of Alt a 1 is still unknown, but elucidation of its structure is a great step towards 
identifying it. The conservation of Cys30 among the closest Alt a 1 homologs strongly suggests 
that they also form dimers which are linked by a covalent bond. The second structure of Alt a 
1 deposited in the PDB (PDB code: 4AUD) does not have Cys30 in its sequence, but it still 
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forms a dimer Figure 22 strongly suggesting that it is possible that homologs in which Cys30 is 
not conserved may still form dimeric structures, in which dimers are stabilized by hydrophobic 
and hydrogen bonding interactions. There is a possibility is that the negatively charged surface 
of the allergen may be involved in the binding of a lig nd and stabilization of the homodimer. 
The result of an experiment performed with the Dynamic Light Scattering method has 
shown that the dimer of recombinant Alt a 1 may have  less compact structure than in the 
crystal or that dimers form a higher order oligomeric assemblies, such as a tetramer (Chruszcz 
et al., 2012a). 
Small molecular compounds which are present in the crystal structure of Alt a 1 - 
4-hydroxy-2,5,6-triaminopyrimidine (4-HTP) and 8-aminocaprylic acid (8-ACA) originate 
from the crystallization solution and most probably their binding is not physiological. 4-HTP is 
located on symmetry elements and 8-ACA is located close to one of the 4-HTP molecules, and 
not on a symmetry element (Figure 20). The orientation of 8-ACA points the amino group 
towards the solution and enables the carboxylic group t  form two hydrogen bonds with an 
amide group of Gln110. The residues Asp37 and Tyr38 provide additional non-specific 
interaction for the 8-aminocaprylate binding (Chruszcz et al., 2012a). Moreover, Alt a 1 does 
not have a binding cavity that is characteristic for lipocalins, streptavidin and other protein with 
the β-barrel fold. However, it can be speculated that the binding of a physiological Alt a 1 ligand 
may induce significant conformational changes resulting in the opening of the hydrophobic 
β-barrel core or that the closed conformation is forced in a crystal (Chruszcz et al., 2012a). 
A search for three-dimensional functional fragments wi h PROFUNC (Laskowski et al., 
2005) did not return any significant hits (Chruszcz et al., 2012a). However, structure of 
streptavidin (PDB codes: 2JGS, 1SWG, 1SWF, and 4GD9) was found to have somewhat 
matching fold, albeit with high rmsd value (~3 Å). Although some similarity of the Alt a 1 to 
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other proteins with a β-barrel can be determined, the structural comparison does not provide 
any direct hint of a possible function of the allerg n. The results obtained from the searches 
with DALI (Holm and Rosenström, 2010) and FATCAT (Ye and Godzik, 2004) showed the 
structure (PDB code: 2Q03) of an uncharacterized protein from Shewanella denitrificans 
(deposited in GenPept under locus YP_563039 which was discontinued and replaced with 
WP_011496472.1) as the top hit (Chruszcz et al., 2012a). Only the proteins β-barrels were 
found as the structures somewhat similar to Alt a 1. The results contained membrane proteins, 
streptavidin, odorant binding proteins, plant transcriptional regulators, RNA binding proteins, 
lipid binding proteins and a few lipocalin antibodies (Bos d 2, Can f 2 and Equ c 1), but these 
allergens contain an α-helix besides β-barrels (Chruszcz et al., 2012a).  
Previous studies of IgE binding to the synthetic peptides of Alt a 1 (Kurup et al., 2003) 
are confirmed with the structural data. The study consist of four peptides derived from the 
sequence of Alt a 1, two of which (K41-P50 and Y54-K63) were shown to bind strongly IgE 
from the sera of Alternaria alternata allergic individuals. The two remaining peptides 
(Y87-D96 and V119-C128) showed weak IgE binding andin the case of the Y87-D96 the 
results were inconsistent. The peptides that were chara terized as strong IgE binding are surface 
exposed and easily accessible for the interaction wth antibodies (Figure 30). These two peptides 
correspond to strands β1 and β2 of the reported by us structure. The peptides that s owed weak 
IgE binding are partially inside of the structure and this may clarify lower affinity towards IgE. 
The localization of the IgE binding epitopes on thesurface of the dimer also provides an 
explanation why it is possible to use a single monoclonal antibody for “sandwich” ELISA 
measurements of Alt a 1. In this method the same antibody is used as both capture and 





Figure 30 Dimer of Alt a 1 shown as a split representation of molecular surface and 
cartoon.  
The IgE antibody–binding peptides are marked in yellow (residues Lys41-Pro50) and blue (residues 
Tyr54-Lys63). Peptides Tyr87-Asp96 and Val119-Cys128, which showed weak IgE antibody binding, 
are shown in light green and dark green, respectively. Each part of the figure is showing a different 




Allergy or hypersensivity to various substances affect almost every citizen of 
industrialized countries. The everyday contact with allergic individuals is commonplace for not 
only allergists, but pediatricians or primary care physicians, who deal with allergic patients 
every day. This is quite different than it was a half century ago, when the diagnosed prevalence 
of allergy was minimal. Allergy care has become a subject for politicians, the media, and, the 
most importantly, is a problem for the allergic indivi uals, their everyday life and their families. 
The elucidation of the three-dimensional structures of the allergens complexed with 
antibodies reveals the conformational epitopes of allergens such as Der p 1 (Lombardero et al., 
1990), that are the main structural features responsible for the allergic response. This approach 
for mapping the antibody epitopes represents a major advantage, compared to the previously 
used strategies that are based on the identification of the antibody-binding peptides that only 
contain the linear epitopes. Therefore, the results of he described structural studies of Group 1 
mite allergens may be used not only to design the exp riments allowing for the identification 
of the IgE binding epitopes, but also to design the recombinant versions of the allergens for the 
application in the immunotherapy (Thomas et al., 2010). 
Bla g 4 is a male cockroach specific protein that is a member of the lipocalin family of 
proteins, and binds small molecule ligands. It binds both tyramine and octopamine, and most 
likely the function of the protein is to deliver a neurotransmitter to a female. The structural 
analysis shows that tyramine binding does not cause ny significant changes in the ligand 
binding site. The results allowed to speculate that t e delivery of tyramine causes post-mating 
inactivation of pheromone production in a female. However, it cannot be excluded that Blag 4 
works as a carrier for both tyramine and octopamine, which is consistent with the NMR and 
ITC results indicating that octopamine binds to Bla g 4 in the same manner as tyramine 
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(Offermann et al., 2014). Comparison of Bla g 4 andPer a 4 structures and sequences suggests 
that these proteins bind different ligands, and therefore have different physiological roles. 
Currently lack of experimental data does not allow f r the identification of Bla g 4 and Per a 4 
fragments that are responsible for cross-reactivity. 
Alt a 1 is a protein produced by common black mold – Alternaria alternata. It is the 
first protein from the entirely new protein family with no previously known structures. The 
structure of Alt a 1 forms a dimer which helps explain the differences observed in previous 
studies (Kurup et al., 2003). The disulfide bridge, formed by Cys30 between the monomers, is 
not necessary to form a dimer, as observed in another Alt a 1 structure (PDB code: 4AUD), but 
it may be involved in the stabilization of the dimer. The other cysteines found in Alt a 1 are 
highly conserved among its homologs which can help explaining their stability. Further studies 
may identify the function of Alt a 1, which can lead to increased knowledge about this unique 
protein family and will provide insights into their biology, fungal allergenicity and the immune 
response to fungal allergens. 
The unique opportunity to analyze different aspects of three inhaled allergens was an 
amazing challenge that allowed for not only the recognition of structures of three selected 
allergens, but showed more detailed knowledge on interfaces in antigen-antibody complexes. 
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